Document:

Registration Rights Agreement, dated December 27, 2012

 Exhibit 4.4 
 EXECUTION VERSION 
 US Foods, Inc. 

$175,000,000.00 8.5% Senior Notes due 2019 
 Exchange and Registration Rights Agreement 
 December 27, 2012

 DEUTSCHE BANK SECURITIES INC. 
 KKR
CAPITAL MARKETS LLC 
 c/o Deutsche Bank Securities Inc. 
 as Representative of the Initial Purchasers 
 60 Wall Street 

New York, New York 10005 
 Ladies and Gentlemen:

 US Foods, Inc. (formerly U.S. Foodservice, Inc.), a Delaware corporation (the “Company”), proposes to issue
and sell upon the terms set forth in the Purchase Agreement (as defined herein) to the purchasers named in Schedule I to the Purchase Agreement (the “Initial Purchasers”), for whom Deutsche Bank Securities Inc. is acting as representative,
an aggregate of $175,000,000 8.5% Senior Notes due 2019 of the Company (the “Notes”), which are unconditionally guaranteed by the guarantors party hereto (each, a “Guarantor” and, collectively, the “Guarantors”).
The Company, the Guarantors and Wilmington Trust, National Association (as successor by merger to Wilmington Trust FSB), as Trustee (the “Trustee”), previously entered into an indenture, dated as of May 11, 2011, and a first
supplemental indenture thereto, dated as of December 6, 2012, and will enter into a second supplemental indenture thereto, to be dated as of the date hereof (together, the “Indenture”). As an inducement to the Initial Purchasers to
enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Initial Purchasers thereunder, the Company agrees with the Initial Purchasers for the benefit of holders (as defined herein) from time to time of the
Registrable Securities (as defined herein) as follows: 
 1. Certain Definitions. For purposes of this Exchange and
Registration Rights Agreement, the following terms shall have the following respective meanings: 
 “Base
Interest” shall mean the interest that would otherwise accrue on the Securities under the terms thereof and the Indenture, without giving effect to the provisions of this Exchange and Registration Rights Agreement. 

 “broker-dealer” shall mean any broker or dealer registered
with the Commission under the Exchange Act. 
 “Commission” shall mean the United States
Securities and Exchange Commission, or any other federal agency at the time administering the Exchange Act or the Securities Act, whichever is the relevant statute for the particular purpose. 

“Effective Time,” in the case of (i) an Exchange Registration, shall mean the time and date as of
which the Commission declares the Exchange Registration Statement effective or as of which the Exchange Registration Statement otherwise becomes effective and (ii) a Shelf Registration, shall mean the time and date as of which the Commission
declares the Shelf Registration Statement effective or as of which the Shelf Registration Statement otherwise becomes effective. 
 “Electing Holder” shall mean any holder of Registrable Securities that has returned a completed and signed Notice and Questionnaire to the Company in accordance with Section 3(d)(ii)
or Section 3(d)(iii) hereof and the instructions set forth in the Notice and Questionnaire. 

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated by the Commission thereunder, as the same may be amended or succeeded from time to time. 

“Exchange Offer” shall have the meaning assigned thereto in Section 2(a) hereof. 

“Exchange Registration” shall have the meaning assigned thereto in Section 3(c) hereof. 

“Exchange Registration Statement” shall have the meaning assigned thereto in Section 2(a) hereof.

 “Exchange Securities” shall have the meaning assigned thereto in Section 2(a) hereof.

 “FINRA” shall have the meaning assigned thereto in Section 3(d)(xvii) hereof.

 “Guarantees” shall mean the Guarantees issued by each Guarantor with respect to the Notes.

  
 2 

 “holder” shall mean each of the Initial Purchasers and
other persons who acquire Registrable Securities from time to time (including any successors or assigns), in each case for so long as such person owns any Registrable Securities. 

“Indenture” shall mean the Indenture, dated as of May 11, 2011, among the Company, the Guarantors
and Wilmington Trust, National Association, as Trustee, as supplemented by the first supplemental indenture thereto, dated as of December 6, 2012, and as supplemented by the second supplemental indenture thereto, to be dated the date hereof,
governing the Company’s 8.5% Senior Notes due 2019, as the same shall be amended or supplemented from time to time. 
 “Issuer Free Writing Prospectus” shall mean any issuer free writing prospectus (as such term is defined in Rule 433(h)(1) under the Securities Act) that has been prepared by the Company.

 “Majority Electing Holders” shall have the meaning assigned thereto in Section 3(d)(vi)
hereof. 
 “Notice and Questionnaire” means a Notice of Registration Statement and Selling
Securityholder Questionnaire substantially in the form of Exhibit A hereto, with such changes thereto as the Company may reasonably determine. 
 “person” shall mean a corporation, limited liability company, association, partnership, organization, business, individual, government or political subdivision thereof or governmental
agency. 
 “Purchase Agreement” shall mean the Purchase Agreement, dated as of December 19,
2012, by and among the Company, the Guarantors and the Initial Purchasers relating to the Securities. 

“Reference Date” shall mean May 11, 2011. 

“Registrable Securities” shall mean the Securities; provided, however, that a Security shall cease to be
a Registrable Security upon the earliest to occur of the following: (i) the Security has been exchanged for an Exchange Security in an Exchange Offer as contemplated in Section 2(a) hereof (provided that any Exchange Security that,
pursuant to the last sentence of Section 2(a), is included in a prospectus for use in connection with resales by broker-dealers shall be deemed to be a Registrable Security with respect to Sections 5 and 8 until resale of such Registrable
Security has been effected within the 90-day period referred to in Section 2(a)); (ii) a Shelf Registration Statement registering such Security under the Securities Act has been declared or becomes effective and such Security has been sold
or otherwise transferred by the holder thereof pursuant to and in a manner contemplated by such effective Shelf Registration Statement; (iii) such Security is sold pursuant to Rule 144 under circumstances in which any legend borne by such
Security relating to restrictions on transferability thereof, under the 

  
 3 

 
Securities Act or otherwise, is removed by the Company or pursuant to the Indenture and an unrestricted CUSIP has been obtained; (iv) the earliest date that is no less than 1,080 days after
the date of the Indenture and on which such Security would be eligible to be sold by a Person that is not an “affiliate” (as defined in Rule 144) of the Company pursuant to Rule 144 without volume restriction; or (v) such Security
shall cease to be outstanding. 
 “Registration Default” shall have the meaning assigned thereto
in Section 2(c) hereof. 
 “Registration Default Period” shall have the meaning assigned
thereto in Section 2(c) hereof. 
 “Registration Expenses” shall have the meaning
assigned thereto in Section 4 hereof. 
 “Resale Period” shall have the meaning assigned
thereto in Section 2(a) hereof. 
 “Restricted Holder” shall mean (i) a holder that is
an affiliate of the Company within the meaning of Rule 405, (ii) a holder that acquires Exchange Securities outside the ordinary course of such holder’s business, (iii) a holder that has arrangements or understandings with any person
to participate in the Exchange Offer for the purpose of distributing Exchange Securities and (iv) a holder that is a broker-dealer, but only with respect to Exchange Securities received by such broker-dealer pursuant to an Exchange Offer in
exchange for Registrable Securities acquired by the broker-dealer directly from the Company. 
 “Rule
144,” “Rule 405” and “Rule 415” shall mean, in each case, such rule promulgated under the Securities Act (or any successor provision), as the same shall be amended from time to time. 

“Securities” shall mean the Notes to be issued and sold to the Initial Purchasers, and securities issued
in exchange therefor or in lieu thereof pursuant to the Indenture. Each Security is entitled to the benefit of the Guarantees and, unless the context otherwise requires, any reference herein to a “Security,” an “Exchange
Security” or a “Registrable Security” shall include a reference to the related Guarantees. 

“Securities Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations
promulgated by the Commission thereunder, as the same may be amended or succeeded from time to time. 

“Shelf Registration” shall have the meaning assigned thereto in Section 2(b) hereof. 

  
 4 

 “Shelf Registration Statement” shall have the meaning
assigned thereto in Section 2(b) hereof. 
 “Special Interest” shall have the meaning
assigned thereto in Section 2(c) hereof. 
 “Trust Indenture Act” shall mean the Trust
Indenture Act of 1939, as amended, and the rules and regulations promulgated by the Commission thereunder, as the same may be amended or succeeded from time to time. 
 Unless the context otherwise requires, any reference herein to a “Section” or “clause” refers to a Section or clause, as the case may be, of this Exchange and Registration Rights
Agreement, and the words “herein,” “hereof’ and “hereunder” and other words of similar import refer to this Exchange and Registration Rights Agreement as a whole and not to any particular Section or other subdivision.

 2. Registration Under the Securities Act. 
 (a) Except as set forth in Section 2(b) below, the Company and the Guarantors agree to use their respective commercially reasonable efforts to file under the Securities Act a registration statement
relating to an offer to exchange (such registration statement, the “Exchange Registration Statement”, and such offer, the “Exchange Offer”) any and all of the Securities for a like aggregate principal amount of debt
securities issued by the Company and guaranteed by the Guarantors, which debt securities and Guarantees are substantially identical to the Securities and the related Guarantees, respectively (and are entitled to the benefits of a trust indenture
which is substantially identical to the Indenture or is the Indenture and which has been qualified under the Trust Indenture Act), except that they have been registered pursuant to an effective registration statement under the Securities Act and do
not contain restrictions on transfer or provisions for the additional interest contemplated in Section 2(c) below or the liquidated damages provided in Section 2(d) below (such new debt securities hereinafter called “Exchange
Securities”). The Company and the Guarantors agree to use their respective commercially reasonable efforts to cause the Exchange Registration Statement to become effective under the Securities Act within 690 days after the Reference Date.
The Exchange Offer will be registered under the Securities Act on the appropriate form and will comply with all applicable tender offer rules and regulations under the Exchange Act. The Company further agrees to use its commercially reasonable
efforts to commence the Exchange Offer promptly after the Exchange Registration Statement becomes effective, hold the Exchange Offer open for the period required by applicable law (including pursuant to any applicable interpretation by the staff of
the Commission), but in any event for at least 10 business days, and exchange the Exchange Securities for all Registrable Securities that have been validly tendered and not withdrawn on or prior to the expiration of the Exchange Offer. If the
Company commences the Exchange Offer, the Company will be entitled to close the Exchange Offer 30 business days after the commencement thereof (or at the end of such shorter period permitted by applicable law), provided that the Company has accepted
all the Registrable Securities validly 

  
 5 

 
tendered in accordance with the terms of the Exchange Offer. The Company and the Guarantors agree (x) to include in the Exchange Registration Statement a prospectus for use in any resales by
any holder of Exchange Securities that is a broker-dealer and (y) to keep such Exchange Registration Statement effective for a period (the “Resale Period”) beginning when Exchange Securities are first issued in the Exchange
Offer and ending upon the earlier of the expiration of the 90th day after the Exchange Offer has been completed or such time as such broker-dealers no longer own any Registrable Securities. 

Each holder participating in the Exchange Offer shall be required to represent to the Company that (i) any Exchange Securities
received by such holder will be acquired in the ordinary course of business, (ii) at the time of the commencement of the Exchange Offer such holder has no arrangements or understanding with any person to participate in the distribution of the
Securities or the Exchange Securities within the meaning of the Securities Act, (iii) such holder is not an “affiliate,” as defined in Rule 405 of the Securities Act, of the Company, (iv) if such holder is not a broker-dealer,
that it is not engaged in, and does not intend to engage in, the distribution of the Exchange Securities, (v) if such holder is a broker-dealer, that it will receive Exchange Securities for its own account in exchange for Securities that were
acquired as a result of market-making activities or other trading activities (other than Securities acquired directly from the Company or any of its affiliates) and that it will deliver a prospectus in connection with any resale of such Exchange
Securities and (vi) such holder is not acting on behalf of any person who could not truthfully make the foregoing representations. 
 (b) If (i) on or prior to the time the Exchange Offer is consummated existing Commission interpretations are changed such that the Exchange Securities or the related Guarantees received by holders
other than Restricted Holders in the Exchange Offer for Registrable Securities are not or would not be, upon receipt, transferable by each such holder without restriction under the Securities Act, (ii) the Exchange Offer has not been completed
within 720 days following the Reference Date, (iii) any Initial Purchaser so requests with respect to Registrable Securities not eligible to be exchanged for Exchange Securities in the Exchange Offer and held by it following consummation of the
Exchange Offer or (iv) any holder (other than an Initial Purchaser) shall be, and shall notify the Company that such holder is, prohibited by law or Commission policy from participating in the Exchange Offer or such holder may not resell the
Exchange Securities acquired in the Exchange Offer to the public without delivering a prospectus and the prospectus contained in the Exchange Registration Statement is not available for such resales by such holder (other than in either case
(x) due solely to the status of such holder as an affiliate of the Company within the meaning of the Securities Act or (y) due to such holder’s inability to make the representations set forth in the second paragraph of
Section 2(a) hereof) and any such holder so requests, the Company and the Guarantors shall, in lieu of (or, in the case of clauses (iii) and (iv), in addition to) conducting the Exchange Offer contemplated by Section 2(a), use
their respective commercially reasonable efforts to file under the Securities Act as promptly as reasonably practicable, a “shelf” registration statement providing for the registration of, and the sale on a continuous or delayed basis by
the holders of, all of the Registrable Securities (or in the case of clause (iii), 

  
 6 

 
the Registrable Securities held by the Initial Purchasers), pursuant to Rule 415 or any similar rule that may be adopted by the Commission (such filing, the “Shelf Registration”
and such registration statement, the “Shelf Registration Statement”). The Company and the Guarantors agree to use their respective commercially reasonable efforts (x) to cause the Shelf Registration Statement to become
effective within 90 days after the date on which the obligation to file such Shelf Registration Statement arises and to use their respective commercially reasonable efforts to cause such Shelf Registration Statement to remain effective for a period
ending on the earlier of the first anniversary of the Effective Time or such shorter period that will terminate when all the Registrable Securities covered by the Shelf Registration Statement have been sold pursuant to the Shelf Registration
Statement or are distributed to the public pursuant to Rule 144 or would be eligible to be sold by a person that is not an “affiliate” (as defined in Rule 144) of the Company pursuant to Rule 144 without volume restriction;
provided, however, that no holder shall be entitled to be named as a selling securityholder in the Shelf Registration Statement or to use the prospectus forming a part thereof for resales of Registrable Securities unless such holder is
an Electing Holder, and (y) after the Effective Time of the Shelf Registration Statement, promptly upon the request of any holder of Registrable Securities that is not then an Electing Holder to take any action reasonably necessary to identify
such holder as a selling securityholder in the Shelf Registration Statement and include any disclosure necessary or advisable in order to comply with the Securities Act or rules and regulations thereunder; provided, however, that
(i) nothing in this clause (y) shall relieve any such holder of the obligation to return a completed and signed Notice and Questionnaire to the Company in accordance with Section 3(d)(iii) hereof and (ii) the Company shall not be
required to take any such action with respect to any such holders more than once every quarter. The Company further agrees to supplement or make amendments to the Shelf Registration Statement, as and when required by the rules, regulations or
instructions applicable to the registration form used by the Company for such Shelf Registration Statement or by the Securities Act or rules and regulations thereunder for shelf registration, and the Company agrees to furnish to each Electing Holder
copies of any such supplement or amendment promptly following its filing with the Commission. 
 Notwithstanding the foregoing,
the Company may suspend the availability of any Shelf Registration Statement (x) for up to an aggregate of 60 days in any consecutive twelve-month period if (i) such action is required by applicable law or (ii) such action is taken by
the Company in good faith and for valid business reasons (not including avoidance of the Company’s obligations hereunder) as determined by the board of directors of the Company or an authorized committee thereof, including the acquisition or
divestiture of assets, or (y) with respect to a Shelf Registration Statement required to be filed due to a failure to consummate the Exchange Offer within the required time period, if such action occurs following the consummation of the
Exchange Offer; provided that the Company shall promptly notify the Electing Holders when the Shelf Registration Statement may once again be used or is effective. 

  
 7 

 (c) The Company and the Initial Purchasers agree that the holders of Registrable Securities
will suffer damages if the Company and the Guarantors fail to fulfill their obligations under this Section 2 and that it would not be feasible to ascertain the extent of such damages with precision. In the event that (i) Exchange
Offer has not been consummated within 720 days after the Reference Date, or (ii) if a Shelf Registration Statement required to be filed under Section 2(b) hereof is not declared effective on or before 90 days after the date on which the
obligation to file the Shelf Registration Statement arises, or (iii) if any Shelf Registration Statement required by Section 2(b) hereof is filed and declared effective, and during the period the Company and the Guarantors are
required to use their respective commercially reasonable efforts to cause the Shelf Registration Statement to remain effective, (x) the Company shall have suspended the Shelf Registration Statement pursuant to Section 2(b) hereof
for more than 60 days in the aggregate in any consecutive twelve-month period and be continuing to suspend the availability of the Shelf Registration Statement or (y) the Shelf Registration Statement shall cease to be effective (other than by
action of the Company pursuant to the second paragraph of Section 2(b) hereof) without being replaced within 90 days by a shelf registration statement that is filed and declared effective (each such event referred to in clauses
(i) through (iii), a “Registration Default” and each period during which a Registration Default has occurred and is continuing, a “Registration Default Period”), then, as liquidated damages for such
Registration Default special interest (“Special Interest”), in addition to the Base Interest, shall accrue on Registrable Securities for the Registration Default Period (but only with respect to one Registration Default at any
particular time) until such time as all Registration Defaults have been cured at a per annum rate of 0.25% for the first 90 days of the Registration Default Period, which rate shall increase by an additional 0.25% during each subsequent 90-day
period, up to a maximum of 0.50% regardless of the number of Registration Defaults that shall have occurred and be continuing. Following the cure of all Registration Defaults, the accrual of Special Interest will cease. A Registration Default under
clause (ii) or (iii) will be deemed cured upon consummation of the Exchange Offer in the case of a Shelf Registration Statement required to be filed due to a failure to consummate the Exchange Offer within the required time
period. 
 (d) If during the 90 day period referenced in the final sentence of the first paragraph of Section 2(a) hereof
any Exchange Offer Registration Statement is suspended by the Company or ceases to be effective such that any broker-dealer that (i) receives Exchange Securities in the Exchange Offer and (ii) is subject to prospectus delivery requirements
cannot fulfill such requirements, the Company shall pay liquidated damages to such broker-dealers in an amount calculated in a manner consistent with that specified above with respect to Registration Defaults. 

(e) The Company and the Guarantors shall take all actions reasonably necessary or advisable to be taken by it to ensure that the
transactions contemplated herein are effected as so contemplated, including all actions necessary or desirable to register the Guarantees under the registration statement contemplated in Section 2(a) or 2(b) hereof, as applicable. 

  
 8 

 (f) Any reference herein to a registration statement or prospectus as of any time shall be
deemed to include any document incorporated, or deemed to be incorporated, therein by reference as of such time and any reference herein to any post-effective amendment to a registration statement or to any prospectus supplement as of any time shall
be deemed to include any document incorporated, or deemed to be incorporated, therein by reference as of such time. 
 3.
Registration Procedures. 
 If the Company and the Guarantors file a registration statement pursuant to Section 2(a)
or Section 2(b), the following provisions shall apply: 
 (a) At or before the Effective Time of the Exchange Registration
or the Shelf Registration, whichever may occur first, the Company shall qualify the Indenture under the Trust Indenture Act. 

(b) In the event that such qualification would require the appointment of a new trustee under the Indenture, the Company shall appoint a
new trustee thereunder pursuant to the applicable provisions of the Indenture. 
 (c) In connection with the Company’s and
each Guarantor’s obligations with respect to the registration of Exchange Securities as contemplated by Section 2(a) (the “Exchange Registration”), if applicable, the Company and the Guarantors shall: 

(i) use their respective commercially reasonable efforts to prepare and file with the Commission an Exchange Registration
Statement on any form which may be utilized by the Company and the Guarantors and which shall permit the Exchange Offer and resales of Exchange Securities by broker-dealers during the Resale Period to be effected as contemplated by
Section 2(a), and use their respective commercially reasonable efforts to cause such Exchange Registration Statement to become effective within 690 days after the Reference Date; 

(ii) prepare and file with the Commission such amendments and supplements to such Exchange Registration Statement and the
prospectus included therein as may be necessary to effect and maintain the effectiveness of such Exchange Registration Statement for the periods and purposes contemplated in Section 2(a) hereof and as may be required by the applicable rules and
regulations of the Commission and the instructions applicable to the form of such Exchange Registration Statement, and promptly provide each broker-dealer holding Exchange Securities with such number of copies of the prospectus included therein (as
then amended or supplemented), in conformity in all material respects with the requirements of the Securities Act and the rules and regulations of the Commission thereunder and the Trust Indenture Act, as such broker-dealer reasonably may request
prior to the expiration of the Resale Period, for use in connection with resales of Exchange Securities; 

  
 9 

 (iii) promptly notify each broker-dealer that has requested or received
copies of the prospectus included in such registration statement, and confirm such advice in writing, (A) when such Exchange Registration Statement or the prospectus included therein or any prospectus amendment or supplement or post-effective
amendment has been filed, and, with respect to such Exchange Registration Statement or any post-effective amendment, when the same has become effective, (B) of any comments by the Commission or by the blue sky or securities commissioner or
regulator of any state with respect to such Exchange Registration Statement or prospectus or any request by the Commission for amendments or supplements to such Exchange Registration Statement or prospectus or for additional information, (C) of
the issuance by the Commission of any stop order suspending the effectiveness of such Exchange Registration Statement or the initiation of any proceedings for that purpose, (D) of the receipt by the Company of any notification with respect to
the suspension of the qualification of the Exchange Securities for sale in any jurisdiction or the initiation of any proceeding for such purpose or (E) at any time during the Resale Period when a prospectus is required to be delivered under the
Securities Act, that such Exchange Registration Statement, prospectus, prospectus amendment or supplement or post-effective amendment does not conform in all material respects to the applicable requirements of the Securities Act and the rules and
regulations of the Commission thereunder and the Trust Indenture Act or contains an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in
the light of the circumstances then existing; 
 (iv) in the event that the Company and the Guarantors would be
required, pursuant to Section 3(c)(iii)(E) above, to notify any broker-dealers holding Exchange Securities, use their respective commercially reasonable efforts to prepare and furnish as soon as practicable to each such broker-dealer a
reasonable number of copies of a prospectus supplemented or amended so that, as thereafter delivered to purchasers of such Exchange Securities during the Resale Period, such prospectus shall conform in all material respects to the applicable
requirements of the Securities Act and the rules and regulations of the Commission thereunder and shall not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein not misleading in the light of the circumstances then existing; 
 (v) use their respective
commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of such Exchange Registration Statement or any post-effective amendment thereto at the earliest practicable date; 

(vi) use their respective commercially reasonable efforts to (A) register or qualify the Exchange Securities under
the state securities laws or blue sky laws of such U.S. jurisdictions as any participating holder of the Registrable Securities 

  
 10 

 
reasonably requests in writing no later than the commencement of the Exchange Offer, (B) keep such registrations or qualifications in effect and comply with such laws so as to permit the
continuance of offers, sales and dealings therein in such jurisdictions until the expiration of the Resale Period and (C) take any and all other actions as may be reasonably necessary to enable each broker-dealer holding Exchange Securities to
consummate the disposition thereof in such jurisdictions; provided, however, that neither the Company nor any Guarantor shall be required for any such purpose to (1) qualify as a foreign corporation in any jurisdiction wherein it would not
otherwise be required to qualify but for the requirements of this
 Section 3(c)(vi), (2) consent to general service of process in any such jurisdiction or (3) make any changes to its certificate of incorporation, by-laws or other
organizational document, as applicable, or any agreement between it and any of its equityholders; 
 (vii)
provide a CUSIP number for all Exchange Securities, not later than the applicable Effective Time; and 
 (viii)
comply in all material respects with all applicable rules and regulations of the Commission, and make generally available to its securityholders as soon as practicable but no later than eighteen months after the effective date of such Exchange
Registration Statement, an earning statement of the Company and its subsidiaries complying with Section 11(a) of the Securities Act (including, at the option of the Company, Rule 158 thereunder). 

(d) In connection with the Company’s and each Guarantor’s obligations with respect to the Shelf Registration, if applicable,
the Company and each Guarantor shall: 
 (i) use its commercially reasonable efforts to prepare and file with the
Commission, within the time period specified in Section 2, a Shelf Registration Statement on any form which may be utilized by the Company and which shall register all of the Registrable Securities (or in the case of a Shelf Registration
Statement filed pursuant to Section 2(b)(iii), the Registrable Securities held by the Initial Purchasers) for resale by the holders thereof in accordance with such method or methods of disposition as may be specified in the applicable
Notice and Questionnaire by such of the holders as, from time to time, may be Electing Holders and use their respective commercially reasonable efforts to cause such Shelf Registration Statement to become effective within the time periods specified
in Section 2(b); 
 (ii) not less than 15 calendar days prior to the Effective Time of the Shelf
Registration Statement, mail the Notice and Questionnaire to the holders of Registrable Securities; no holder shall be entitled to be named as a selling securityholder in the Shelf Registration Statement as of the Effective Time, and no holder shall
be entitled to use the prospectus forming a part thereof for resales of Registrable Securities at any time, unless such holder has returned a completed 

  
 11 

 
and signed Notice and Questionnaire to the Company by the deadline for response set forth therein; provided, however, holders of Registrable Securities shall have at least 13 calendar days from
the date on which the Notice and Questionnaire is first mailed to such holders to return a completed and signed Notice and Questionnaire to the Company; 
 (iii) after the Effective Time of the Shelf Registration Statement, upon the request of any holder of Registrable Securities that is not then an Electing Holder, promptly send a Notice and Questionnaire
to such holder; provided that the Company shall not be required to take any action to name such holder as a selling securityholder in the Shelf Registration Statement or to enable such holder to use the prospectus forming a part thereof for resales
of Registrable Securities until such holder has returned a completed and signed Notice and Questionnaire to the Company; 
 (iv) as soon as practicable prepare and file with the Commission such amendments and supplements to such Shelf Registration Statement and the prospectus included therein as may be necessary to effect and
maintain the effectiveness of such Shelf Registration Statement for the period specified in Section 2(b) hereof and as may be required by the applicable rules and regulations of the Commission and the instructions applicable to the form
of such Shelf Registration Statement, and furnish to the Electing Holders copies of any such supplement or amendment as soon as practicable following its filing with the Commission. Notwithstanding the foregoing, the Company may suspend the
availability of any Shelf Registration Statement as provided in the second paragraph of Section 2(b); 
 (v) comply in all material respects with the provisions of the Securities Act with respect to the disposition of all of the Registrable Securities covered by such Shelf Registration Statement in
accordance with the intended methods of disposition by the Electing Holders provided for in such Shelf Registration Statement; 
 (vi) for a reasonable period prior to the filing of such Shelf Registration Statement, and throughout the period specified in Section 2(b), as applicable, make reasonably available at reasonable
times at the Company’s principal place of business or such other reasonable place for inspection by a representative of, and not more than one counsel acting for, Electing Holders holding at least a majority in aggregate principal amount of the
Registrable Securities at the time outstanding (the “Majority Electing Holders”) and any underwriter participating in the distribution of the Registrable Securities being sold (including any person who may be deemed an underwriter
within the meaning of Section 2(a)(ii) of the Securities Act) such relevant financial and other pertinent information and books and records of the Company, and use its commercially reasonable efforts to cause the officers, employees, counsel
and independent certified public accountants of 

  
 12 

 
the Company to respond to such inquiries, as shall be reasonably necessary to conduct a reasonable investigation within the meaning of Section 11 of the Securities Act; provided, however,
that the foregoing investigation and information gathering shall be coordinated on behalf of all such parties by one counsel designated by and on behalf of all such parties and provided, further, that each such party shall be required (pursuant to
an agreement in form and substance reasonably satisfactory to the Company) to maintain in confidence and not to disclose to any other person any information or records reasonably designated by the Company as being confidential, until such time as
(A) such information becomes a matter of public record (whether by virtue of its inclusion in such registration statement or otherwise except as a result of a breach of this or any other obligation of confidentiality to the Company known to
such party), or (B) such person shall be required so to disclose such information pursuant to a subpoena or order of any court or other governmental agency or body having jurisdiction over the matter (subject to the requirements of such order,
and only after such person shall have given the Company prompt prior written notice of such requirement, to the extent legally permissible, so that the Company, at its expense, may undertake appropriate action to prevent disclosure of such
information or records), or (C) in order to establish a due diligence defense, such person shall so disclose such information or (D) such information is required to be set forth in such Shelf Registration Statement or the prospectus
included therein or in an amendment to such Shelf Registration Statement or an amendment or supplement to such prospectus in order that such Shelf Registration Statement, prospectus, amendment or supplement, as the case may be, complies with
applicable requirements of the federal securities laws and the rules and regulations of the Commission and does not contain an untrue statement of a material fact or omit to state therein a material fact required to be stated therein or necessary to
make the statements therein not misleading in the light of the circumstances then existing; 
 (vii) promptly
notify each of the Electing Holders and any managing underwriter thereof and confirm such advice in writing, (A) when such Shelf Registration Statement or the prospectus included therein or any prospectus amendment or supplement or
post-effective amendment or related Issuer Free Writing Prospectus, has been filed, and, with respect to such Shelf Registration Statement or any post-effective amendment, when the same has become effective, (B) of any comments by the
Commission or by the blue sky or securities commissioner or regulator of any state with respect to such Shelf Registration Statement or prospectus or any request by the Commission for amendments or supplements to such Shelf Registration Statement or
prospectus or related Issuer Free Writing Prospectus, or for additional information, (C) of the issuance by the Commission of any stop order suspending the effectiveness of such Shelf Registration Statement or the initiation of any proceedings
for that purpose, (D) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Registrable Securities for sale in any jurisdiction or the

  
 13 

 
initiation of any proceeding for such purpose or (E) if at any time when a prospectus is required to be delivered under the Securities Act, that such Shelf Registration Statement,
prospectus, prospectus amendment or supplement or post-effective amendment does not conform in all material respects to the applicable requirements of the Securities Act and the rules and regulations of the Commission thereunder or contains an
untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing; 

(viii) use their respective commercially reasonable efforts to obtain the withdrawal of any order suspending the
effectiveness of such registration statement or any post-effective amendment thereto at the earliest practicable date; 
 (ix) if requested by any managing underwriter or the Majority Electing Holders, promptly incorporate in a prospectus supplement or post-effective amendment such information as is required by the
applicable rules and regulations of the Commission and as such managing underwriter or such Majority Electing Holders shall specify should be included therein relating to the terms of the sale of such Registrable Securities, including information
with respect to the principal amount of Registrable Securities being sold by such Majority Electing Holders or to any underwriters, the names and descriptions of such Majority Electing Holders or underwriters, the offering price of such Registrable
Securities and any discount, commission or other compensation payable in respect thereof, the purchase price being paid therefor by such underwriters and with respect to any other terms of the offering of the Registrable Securities to be sold by
such Majority Electing Holders or to such underwriters; and make all required filings of such prospectus supplement or post-effective amendment as soon as practicable after notification of the matters to be incorporated in such prospectus supplement
or post-effective amendment; 
 (x) furnish to each Electing Holder, and each underwriter, if any, thereof such
number of copies of such Shelf Registration Statement (excluding exhibits thereto and documents incorporated by reference therein) and of the prospectus included in such Shelf Registration Statement (including each preliminary prospectus), and any
related Issuer Free Writing Prospectus, in conformity in all material respects with the applicable requirements of the Securities Act and the rules and regulations of the Commission thereunder, as such Electing Holder and underwriter, if any, may
reasonably request in order to facilitate the offering and disposition of the Registrable Securities owned by such Electing Holder or underwritten by such underwriter and to permit such Electing Holder and underwriter, if any, to satisfy the
prospectus delivery requirements of the Securities Act; and the Company hereby consents to the use of such prospectus (including such preliminary prospectus) and any amendment or supplement thereto and any related Issuer Free Writing Prospectus, by
each such Electing Holder and by any such underwriter, in each case in the form most recently provided to such person by the Company, in connection with the offering and sale of the Registrable Securities covered by the prospectus (including such
preliminary prospectus) or any supplement or amendment thereto; 

  
 14 

 (xi) use their respective commercially reasonable efforts to
(A) register or qualify the Registrable Securities to be included in such Shelf Registration Statement under such state securities laws or blue sky laws of such U.S. jurisdictions as any Electing Holder and managing underwriter, if any, thereof
shall reasonably request, (B) keep such registrations or qualifications in effect and comply with such laws so as to permit the continuance of offers, sales and dealings therein in such jurisdictions during the period the Shelf Registration is
required to remain effective under Section 2(b) above and for so long as may be necessary to enable any such Electing Holder or underwriter to complete its distribution of Securities pursuant to such Shelf Registration Statement and
(C) take any and all other actions as may be reasonably necessary to enable each such Electing Holder and underwriter, if any, to consummate the disposition in such jurisdictions of such Registrable Securities; provided, however,
that neither the Company nor any Guarantor shall be required for any such purpose to (1) qualify as a foreign corporation in any jurisdiction wherein it would not otherwise be required to qualify but for the requirements of this
Section 3(d)(xi), (2) consent to general service of process in any such jurisdiction or (3) make any changes to its certificate of incorporation, bylaws or other organizational document, or any agreement between it and any of
its equityholders; 
 (xii) unless any Registrable Securities shall be in book-entry only form, cooperate with
the Electing Holders and the managing underwriters, if any, to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold, which certificates shall not bear any restrictive legends; and, in the case
of an underwritten offering, enable such Registrable Securities to be in such denominations and registered in such names as the managing underwriter may request a reasonable amount of time prior to any sale of the Registrable Securities; 

(xiii) provide a CUSIP number for all Registrable Securities, not later than the applicable Effective Time; 

(xiv) enter into one or more underwriting agreements in customary form, including customary provisions relating to
indemnification and contribution, and use their respective commercially reasonable efforts to take such other actions, if any, in connection therewith as any Electing Holders aggregating at least 20% in aggregate principal amount of the Registrable
Securities at the time outstanding shall reasonably request in order to expedite or facilitate the disposition of such Registrable Securities; 
 (xv) if requested by the Majority Electing Holders or if the offering contemplated by the Shelf Registration is an underwritten offering, use their respective commercially reasonable efforts to
(A) make such representations and 

  
 15 

 
warranties to the Electing Holders and the underwriters, if any, thereof in form, substance and scope as are customarily made in connection with an offering of debt securities pursuant to any
underwriting agreement; (B) obtain an opinion of counsel to the Company in customary form subject to customary limitations, assumptions and exclusions and covering such matters, of the type customarily covered by such an opinion, as the
managing underwriters, if any, or as any Electing Holders of at least 20% in aggregate principal amount of the Registrable Securities at the time outstanding may reasonably request, addressed to the Electing Holders and the underwriters, if any,
thereof and dated the effective date of such Shelf Registration Statement (and if such Shelf Registration Statement contemplates an underwritten offering of a part or all of the Registrable Securities, dated the date of the closing under the
underwriting agreement relating thereto); (C) obtain a “cold comfort” letter or letters from the independent certified public accountants of the Company addressed to the selling Electing Holders or the underwriters, if any, thereof,
dated (i) the effective date of such Shelf Registration Statement and (ii) if such Shelf Registration Statement contemplates an underwritten offering, dated the date of the closing under the underwriting agreement relating thereto, such
letter or letters to be in customary form and covering such matters of the type customarily covered by letters of such type, subject to receipt of appropriate documentation as contemplated, and only if permitted, by Statement of Auditing Standards
No. 72; and (D) deliver such customary documents and certificates, including officers’ certificates, as may be reasonably requested by the Majority Electing Holders and the managing underwriters, if any, thereof, 

(xvi) notify in writing each holder of Registrable Securities of any proposal by the Company to amend or waive any
provision of this Exchange and Registration Rights Agreement pursuant to Section 8(g) hereof and of any amendment or waiver effected pursuant thereto, each of which notices shall contain the text of the amendment or waiver proposed or
effected, as the case may be; 
 (xvii) in the event that any broker-dealer registered under the Exchange Act
shall underwrite any Registrable Securities or participate as a member of an underwriting syndicate (within the meaning of the Conduct Rules (the “Conduct Rules”) of the Financial Industry Regulatory Authority, Inc.
(“FINRA”) or any successor thereto, as amended from time to time) thereof as an underwriter, use commercially reasonable efforts to provide information to assist such broker-dealer in complying with the requirements of such Conduct
Rules; 
 (xviii) comply in all material respects with all applicable rules and regulations of the Commission,
and make generally available to its securityholders as soon as practicable but in any event not later than eighteen months after the effective date of such Shelf Registration Statement, an earning statement of the Company and its subsidiaries
complying with Section 11(a) of the Securities Act (including, at the option of the Company, Rule 158 thereunder); and 

  
 16 

 (xix) take all reasonable action to ensure that any Issuer Free Writing
Prospectus utilized in connection with any registration covered by Section 4(d) is filed in accordance with the Securities Act to the extent required thereby and, when taken together with the related prospectus, prospectus supplement and
related documents, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statement therein, in the light of the circumstances under which they were made, not misleading. 

(e) In the event that the Company would be required, pursuant to Section 3(d)(vii)(E) above, to notify the Electing Holders and the
managing underwriters, if any, thereof, the Company shall as soon as practicable prepare and furnish to each of the Electing Holders and to each such underwriter, if any, a reasonable number of copies of a prospectus supplemented or amended so that,
as thereafter delivered to purchasers of Registrable Securities, such prospectus shall conform in all material respects to the applicable requirements of the Securities Act and the rules and regulations of the Commission thereunder and shall not
contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing. Each broker-dealer and Electing
Holder agrees that upon receipt of any notice from the Company pursuant to Section 3(c)(iii)(E) or Section 3(d)(vii)(E) hereof, such broker-dealer or Electing Holder shall forthwith discontinue the disposition of Registrable Securities
pursuant to the Exchange Registration Statement or Shelf Registration Statement applicable to such Registrable Securities until such broker-dealer or Electing Holder shall have received copies of such amended or supplemented prospectus, and if so
directed by the Company, such broker-dealer or Electing Holder shall deliver to the Company (at the Company’s expense) all copies, other than permanent file copies, then in such broker-dealer’s or Electing Holder’s possession of the
prospectus covering such Registrable Securities at the time of receipt of such notice. 
 (f) In the event of a Shelf
Registration, in addition to the information required to be provided by each Electing Holder in its Notice and Questionnaire, the Company may require such Electing Holder to furnish to the Company such additional information regarding such Electing
Holder and such Electing Holder’s intended method of distribution of Registrable Securities as may be required in order to comply with the Securities Act. Each such Electing Holder agrees to notify the Company as promptly as practicable of any
inaccuracy or change in information previously furnished by such Electing Holder to the Company or of the occurrence of any event in either case as a result of which any prospectus relating to such Shelf Registration contains or would contain an
untrue statement of a material fact regarding such Electing Holder or such Electing Holder’s intended method of disposition of such Registrable Securities or omits to state any material fact regarding such Electing Holder or such Electing
Holder’s intended method of disposition of such Registrable Securities required to be stated therein or necessary to make the statements therein not misleading in the light of the 

  
 17 

 
circumstances then existing, and promptly to furnish to the Company any additional information required to correct and update any previously furnished information or required so that such
prospectus shall not contain, with respect to such Electing Holder or the disposition of such Registrable Securities, an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein not misleading in the light of the circumstances then existing. 
 4. Registration Expenses.

 The Company and the Guarantors, jointly and severally, agree to bear and to pay or cause to be paid promptly all expenses
incident to the Company’s and the Guarantors’ performance of or compliance with this Exchange and Registration Rights Agreement, including (a) all Commission and any FINRA registration, filing and review fees and expenses including
the reasonable fees and disbursements of counsel for the underwriters and the Majority Electing Holders, in each case, in connection with such registration, filing and review, (b) all fees and expenses in connection with the qualification of
the Securities for offering and sale under the State securities and blue sky laws referred to in Sections 3(c)(vi) and 3(d)(xi) hereof and determination of their eligibility for investment under the laws of such jurisdictions as any
managing underwriters or the Electing Holders may reasonably designate, including the reasonable fees and disbursements of counsel for the Electing Holders or underwriters in connection with such qualification and determination, (c) all
expenses relating to the preparation, printing, production, distribution and reproduction of each registration statement required to be filed hereunder, each prospectus included therein or prepared for distribution pursuant hereto, each amendment or
supplement to the foregoing, any related Issuer Free Writing Prospectus, the expenses of preparing the Securities for delivery and the expenses of printing or producing any underwriting agreements, agreements among underwriters, selling agreements
and blue sky or legal investment memoranda and all other documents in connection with the offering, sale or delivery of Securities to be disposed of (including certificates representing the Securities), (d) messenger, telephone and delivery
expenses relating to the offering, sale or delivery of Securities and the preparation of documents referred in clause (c) above, (e) reasonable fees and expenses of the Trustee under the Indenture, any agent of the Trustee and any counsel
for the Trustee and of any collateral agent or custodian, (f) internal expenses (including all salaries and expenses of the Company’s and the Guarantors’ officers and employees performing legal or accounting duties), (g) fees,
disbursements and expenses of counsel of the Company and independent certified public accountants of the Company (including the expenses of any opinions or “cold comfort” letters required by or incident to such performance and compliance),
(h) reasonable fees, disbursements and expenses of any “qualified independent underwriter” engaged pursuant to Section 3(d)(xvii) hereof, (i) the reasonable fees, disbursements and expenses of one counsel for the Electing
Holders retained in connection with a Shelf Registration, as selected by the Electing Holders of at least a majority in aggregate principal amount of the Registrable Securities held by Electing Holders (which counsel shall be reasonably satisfactory
to the Company), (j) any fees charged by securities rating services for rating the Securities, and (k) fees, expenses 

  
 18 

 
and disbursements of any other persons, including special experts, retained by the Company in connection with such registration (collectively, the “Registration Expenses”). To
the extent that any Registration Expenses are incurred, assumed or paid by any holder of Registrable Securities or any placement or sales agent therefor or underwriter thereof, the Company and the Guarantors, jointly and severally, shall reimburse
such person for the full amount of the Registration Expenses so incurred, assumed or paid promptly after receipt of a request therefor. Notwithstanding the foregoing, the holders of the Registrable Securities being registered shall pay all agency
fees and commissions and underwriting discounts and commissions attributable to the sale of such Registrable Securities and the fees and disbursements of any counsel or other advisors or experts retained by such holders (severally or jointly), other
than the counsel and experts specifically referred to above. 
 5. Indemnification, Contribution. 

(a) Indemnification by the Company. The Company and the Guarantors, jointly and severally, agree to indemnify and hold harmless
each of the broker-dealers whose Registrable Securities are included in an Exchange Registration Statement, each Electing Holder whose Registrable Securities are included in a Shelf Registration Statement and each person, if any, who controls any
such Electing Holder, or such broker dealer within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act as follows: 

(i) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, arising out of any untrue
statement or alleged untrue statement of a material fact contained in any Exchange Registration Statement or Shelf Registration Statement, as the case may be, or any amendment or supplement thereto, pursuant to which Exchange Securities or
Registrable Securities were registered under the Securities Act, including all documents incorporated therein by reference, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the
statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact contained in any prospectus contained in any such Exchange Registration Statement or Shelf Registration Statement, as the case
may be, or any amendment or supplement thereto, or in any Issuer Free Writing Prospectus related thereto (when taken together with related prospectus or prospectus supplement), or the omission or alleged omission therefrom of a material fact
necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; 
 (ii) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding
by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that any such settlement is effected with the prior
written consent of the Company; and 

  
 19 

 (iii) against any and all expense whatsoever, as incurred (including the
reasonable fees and disbursements of counsel chosen by any indemnified party), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or
threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under subparagraph (i) or (ii) above; provided,
however, that the Company and the Guarantors shall not be liable to any such person to the extent such loss, liability, claim, damage or expense arises out of any untrue statement or omission or alleged untrue statement or omission made in reliance
upon and in conformity with written information furnished to the Company by or on behalf of such person expressly for use in an Exchange Registration Statement or Shelf Registration Statement (or any amendment thereto), any related prospectus (or
any amendment or supplement thereto), or any Issuer Free Writing Prospectus related thereto. 
 (b) Indemnification by the
Holders. Each Electing Holder, severally, but not jointly, agrees to (i) indemnify and hold harmless the Company, the Guarantors and the other Electing Holders, and each of their respective directors and officers, and each person, if any,
who controls the Company, the Guarantors or any other Electing Holder within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, against any and all loss, liability, claim, damage and expense
described in the indemnity contained in Section 5(a) hereof, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in any Shelf Registration Statement (or any amendment
thereto), or any prospectus included therein (or any amendment or supplement thereto) or any related Issuer Free Writing Prospectus in reliance upon and in conformity with written information furnished to the Company by or on behalf of such Electing
Holder expressly for use in the Shelf Registration Statement (or any amendment thereto) or such prospectus (or any amendment or supplement thereto) or any related Issuer Free Writing Prospectus, and (ii) reimburse the Company for any legal or
other expenses reasonably incurred by the Company in connection with investigating or defending any such action or claim as such expenses are incurred; provided, however, that no such holder shall be liable for any claims hereunder in
excess of the amount of net proceeds received by such Electing Holder from the sale of Registrable Securities pursuant to such Shelf Registration Statement. 
 (c) Notices of Claims, Etc. Each indemnified party shall give written notice promptly to each indemnifying party of any action or proceeding commenced against it in respect of which indemnity may
be sought hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying party from any liability hereunder to the extent it is not materially prejudiced as a result thereof and in any event shall not relieve it from
any liability which it may have otherwise than on account of this 

  
 20 

 
indemnity agreement. In case any such action shall be brought against any indemnified party and it shall notify an indemnifying party of the commencement thereof, such indemnifying party shall be
entitled to participate therein and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party (who shall not, except
with the consent of the indemnified party, be counsel to the indemnifying party) and, after notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, such indemnifying party shall not be liable to
such indemnified party for any legal expenses of other counsel or any other expenses, in each case subsequently incurred by such indemnified party, in connection with the defense thereof other than reasonable costs of investigation). To the extent
that an indemnifying party does not assume the defense of any such action, in no event shall such indemnifying party be liable for the fees and expenses of more than one counsel (in addition to any local counsel) separate from its own counsel for
all indemnified parties in connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances. No indemnifying party shall, without the prior written
consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever
in respect of which indemnification or contribution could be sought under this Section 5 (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an
unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on
behalf of any indemnified party. 
 (d) Contribution. If the indemnification provided for in this Section 5
is for any reason unavailable to or insufficient to hold harmless an indemnified party in respect of any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount of
such losses, liabilities, claims, damages and expenses incurred by such indemnified party, as incurred, in such proportion as is appropriate to reflect the relative benefits received by the Company and the Guarantors, on the one hand, and the
holders, on the other hand, from the issuance and sale by the Company of the Notes (which in the case of the Company and the Guarantors shall be deemed to be equal to the total gross proceeds to the Company and the Guarantors from the issuance and
sale of the Notes), the relative fault of the indemnifying party and the indemnified party in connection with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses, as well as any other relevant
equitable considerations. The relative fault of the indemnifying party and the indemnified party shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged
omission to state a material fact relates to information supplied by such indemnifying party or by such indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or
omission. The parties hereto agree that it would not be just and equitable if contribution 

  
 21 

 
pursuant to this Section 5(d) were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above
in this Section 5(d). The aggregate amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party and referred to above in this Section 5(d) shall be deemed to include any reasonable
out-of-pocket legal or other expenses reasonably incurred by such indemnified party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or
any claim whatsoever based upon any such untrue or alleged untrue statement or omission or alleged omission. Notwithstanding the provisions of this Section 5(d), no Electing Holder shall be required to contribute any amount in excess of
the amount by which the dollar amount of the proceeds received by such holder from the sale of any Registrable Securities exceeds the amount of any damages which the Electing Holder has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty
of such fraudulent misrepresentation. 
 For purposes of this Section 5(d), each person, if any, who controls any
Electing Holder within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act shall have the same rights to contribution as such Electing Holder, and each director of the Company, and each person,
if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act shall have the same rights to contribution as the Company. The Electing Holders’ obligation in
this Section 5(d) to contribute shall be several in proportion to the principal amount of Registrable Securities registered by them and not joint. 
 6. Underwritten Offerings. 
 (a) Selection of Underwriters. If any of
the Registrable Securities covered by the Shelf Registration are to be sold pursuant to an underwritten offering, the managing underwriter or underwriters thereof shall be designated by Electing Holders holding at least a majority in aggregate
principal amount of the Registrable Securities to be included in such offering, subject to the consent of the Company (which shall not be unreasonably withheld or delayed) and such Electing Holders shall be responsible for all underwriting discounts
and commissions in connection therewith. 
 (b) Participation by Holders. Each holder of Registrable Securities hereby
agrees with each other such holder that no such holder may participate in any underwritten offering hereunder unless such holder (i) agrees to sell such holder’s Registrable Securities on the basis provided in any underwriting arrangements
approved by the persons entitled hereunder to approve such arrangements and (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents reasonably required under the terms of such
underwriting arrangements. 

  
 22 

 7. Rule 144. 
 The Company covenants to the holders of Registrable Securities that to the extent it shall be required to do so under the Exchange Act, the Company shall timely file the reports required to be filed by it
under the Exchange Act or the Securities Act (including the reports under Section 13 or 15(d) of the Exchange Act referred to in subparagraph (c)(1) of Rule 144 adopted by the Commission under the Securities Act) and the rules and regulations
adopted by the Commission thereunder, and shall take such further action as any holder of Registrable Securities may reasonably request, all to the extent required from time to time to enable such holder to sell Registrable Securities without
registration under the Securities Act within the limitations of the exemption provided by Rule 144 under the Securities Act, as such Rule may be amended from time to time, or any similar or successor rule or regulation hereafter adopted by the
Commission. Upon the request of any holder of Registrable Securities in connection with that holder’s sale pursuant to Rule 144, the Company shall deliver to such holder a written statement as to whether it has complied with such requirements.
The Company will be deemed to have satisfied the foregoing requirements if any parent entity of the Company files such reports and takes such actions of the types otherwise so required, in each case within the applicable time periods. 

8. Miscellaneous. 
 (a) No Inconsistent Agreements. The Company and the Guarantors represent, warrant, covenant and agree that they have not granted, and shall not grant, registration rights with respect to
Registrable Securities or any other securities which would be inconsistent with the terms contained in this Exchange and Registration Rights Agreement. 
 (b) Notices. All notices, requests, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered by hand, if delivered
personally or by courier, or three days after being deposited in the mail (registered or certified mail, postage prepaid, return receipt requested) as follows: (i) if to the Company, to it at US Foods, Inc., 9399 West Higgins Road, Suite 500,
Rosemont, Illinois 60018, Attention: General Counsel, with a copy to Steven J. Slutzky, Esq., Debevoise & Plimpton LLP, 919 Third Avenue, New York, NY 10022, (ii) if to a holder, to the address of such holder set forth in the security
register or other records of the Company or to such other address as the Company or any such holder may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt, and
(iii) if to the Initial Purchasers, c/o Deutsche Bank Securities Inc., 60 Wall Street, New York, New York 10005, Attention: High Yield Debt Syndicate Desk, Third Floor, with a copy to the attention of the General Counsel, 36th Floor and with a
copy to John A. Tripodoro, Esq., Cahill Gordon & Reindel LLP, 80 Pine Street, New York, New York 10005. 
 (c)
Parties in Interest. All the terms and provisions of this Exchange and Registration Rights Agreement shall be binding upon, shall inure to the benefit of 

  
 23 

 
and shall be enforceable by the parties hereto and the holders from time to time of the Registrable Securities and the respective successors and assigns of the parties hereto and such holders. In
the event that any transferee of any holder of Registrable Securities shall acquire Registrable Securities, in any manner, whether by gift, bequest, purchase, operation of law or otherwise, such transferee shall, without any further writing or
action of any kind, be deemed a beneficiary hereof for all purposes and such Registrable Securities shall be held subject to all of the terms of this Exchange and Registration Rights Agreement, and by taking and holding such Registrable Securities
such transferee shall be entitled to receive the benefits of, and be conclusively deemed to have agreed to be bound by all of the applicable terms and provisions of this Exchange and Registration Rights Agreement. If the Company shall so request,
any such successor, assign or transferee shall agree in writing to acquire and hold the Registrable Securities subject to all of the applicable terms hereof. 
 (d) Survival. The respective indemnities, agreements, representations, warranties and each other provision set forth in this Exchange and Registration Rights Agreement or made pursuant hereto shall
remain in full force and effect regardless of any investigation (or statement as to the results thereof) made by or on behalf of any holder of Registrable Securities, any director, officer or partner of such holder, any agent or underwriter or any
director, officer or partner thereof, or any controlling person of any of the foregoing, and shall survive delivery of and payment for the Registrable Securities pursuant to the Purchase Agreement and the transfer and registration of Registrable
Securities by such holder and the consummation of an Exchange Offer. 
 (e) Governing Law. This Exchange and Registration
Rights Agreement shall be governed by and construed in accordance with the laws of the State of New York. 
 (f)
Headings. The descriptive headings of the several Sections and paragraphs of this Exchange and Registration Rights Agreement are inserted for convenience only, do not constitute a part of this Exchange and Registration Rights Agreement and
shall not affect in any way the meaning or interpretation of this Exchange and Registration Rights Agreement. 
 (g) Entire
Agreement; Amendments. This Exchange and Registration Rights Agreement and the other writings referred to herein (including the Indenture and the form of Securities) or delivered pursuant hereto which form a part hereof contain the entire
understanding of the parties with respect to its subject matter. This Exchange and Registration Rights Agreement supersedes all prior agreements and understandings between the parties with respect to its subject matter. This Exchange and
Registration Rights Agreement may be amended and the observance of any term of this Exchange and Registration Rights Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) only by a written
instrument duly executed by the Company and the holders of at least a majority in aggregate principal amount of the Registrable Securities at the time outstanding. Each holder of any Registrable Securities at the time or thereafter outstanding shall
be bound by any amendment or waiver effected 

  
 24 

 
pursuant to this Section 8(g), whether or not any notice, writing or marking indicating such amendment or waiver appears on such Registrable Securities or is delivered to such holder.

 (h) Counterparts. This Exchange and Registration Rights Agreement may be executed by the parties in counterparts, each
of which shall be deemed to be an original, but all such respective counterparts shall together constitute one and the same instrument. 
 (i) Severability. If any provision of this Exchange and Registration Rights Agreement, or the application thereof in any circumstance, is held to be invalid, illegal or unenforceable in any respect
for any reason, the validity, legality and enforceability of such provision in every other respect and of the remaining provisions contained in this Exchange and Registration Rights Agreement shall not be affected or impaired thereby. 

If the foregoing is in accordance with your understanding, please sign and return to us six counterparts hereof, and upon the acceptance
hereof by you, on behalf of each of the Initial Purchasers, this letter and such acceptance hereof shall constitute a binding agreement between each of the Initial Purchasers, the Guarantors and the Company. 

[Signature Pages Follow] 

  
 25 

 Exhibit A 
 US Foods, Inc. 
 INSTRUCTION TO DTC PARTICIPANTS 

(Date of Mailing) 

URGENT - IMMEDIATE ATTENTION REQUESTED 
 DEADLINE FOR RESPONSE: [DATE]1 
 The Depository Trust Company (“DTC”) has identified you as a DTC Participant
through which beneficial interests in US Foods, Inc. (formerly U.S. Foodservice, Inc., the “Company”) 8.5% Senior Notes due 2019 (the “Securities”) are held. 
 The Company is in the process of registering the Securities under the Securities Act of 1933 for resale by the beneficial owners thereof. In order to have their Securities included in the registration
statement, beneficial owners must complete and return the enclosed Notice of Registration Statement and Selling Securityholder Questionnaire. 

It is important that beneficial owners of the Securities receive a copy of the enclosed materials as soon as possible as their rights to have the
Securities included in the registration statement depend upon their returning the Notice and Questionnaire by [Deadline For Response]. Please forward a copy of the enclosed documents to each beneficial owner that holds interests in the Securities
through you. If you require more copies of the enclosed materials or have any questions pertaining to this matter, please contact US Foods, Inc., 9399 West Higgins Road, Suite 500, Rosemont, Illinois 60018. 

 
  

	1	Not less than 28 calendar days from date of mailing. 

  
 A-1

 US Foods, Inc. 
 Notice of Registration Statement 
 and 

Selling, Securityholder Questionnaire 
 (Date) 
 Reference is hereby made to the Exchange and Registration Rights Agreement (the
“Exchange and Registration Rights Agreement”) among US Foods, Inc. (formerly U.S. Foodservice, Inc., the “Company”), the Guarantors party thereto and the Initial Purchasers named therein. Pursuant to the Exchange
and Registration Rights Agreement, the Company has filed with the United States Securities and Exchange Commission (the “Commission”) a registration statement on Form [    ] (the “Shelf Registration
Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Company’s 8.5% Senior Notes due 2019 (the “Securities”). A copy of
the Exchange and Registration Rights Agreement is attached hereto. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Exchange and Registration Rights Agreement. 

Each beneficial owner of Registrable Securities (as defined below) is entitled to have the Registrable Securities beneficially owned by it included in
the Shelf Registration Statement. In order to have Registrable Securities included in the Shelf Registration Statement, this Notice of Registration Statement and Selling Securityholder Questionnaire (“Notice and Questionnaire”) must
be completed, executed and delivered to the Company’s counsel at the address set forth herein for receipt ON OR BEFORE [Deadline for Response]. Beneficial owners of Registrable Securities who do not complete, execute and return this Notice and
Questionnaire by such date (i) will not be named as selling securityholders in the Shelf Registration Statement and (ii) may not use the Prospectus forming a part thereof for resales of Registrable Securities. 

Certain legal consequences arise from being named as a selling securityholder in the Shelf Registration Statement and related Prospectus. Accordingly,
holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Shelf Registration Statement and related
Prospectus. 
 The term “Registrable Securities” is defined in the Exchange and Registration Rights Agreement. 

  
 A-2

 ELECTION 
 The undersigned holder (the “Selling Securityholder”) of Registrable Securities hereby elects to include in the Shelf Registration Statement the Registrable Securities beneficially owned
by it and listed below in Item (3). The undersigned, by signing and returning this Notice and Questionnaire, agrees to be bound with respect to such Registrable Securities by the terms and conditions of this Notice and Questionnaire and the Exchange
and Registration Rights Agreement, including, without limitation, Section 5 of the Exchange and Registration Rights Agreement, as if the undersigned Selling Securityholder were an original party thereto. 

Upon any sale of Registrable Securities pursuant to the Shelf Registration Statement, the Selling Securityholder will be required to deliver to the
Company and Trustee the Notice of Transfer set forth in Exhibit B to the Exchange and Registration Rights Agreement. 

  
 A-3

 The Selling Securityholder hereby provides the following information to the Company and represents and
warrants that such information is accurate and complete: 
 QUESTIONNAIRE 

 

	 	1.	(a) Full Legal Name of Selling Securityholder: 

  

	 	(b)	Full Legal Name of Registered Holder (if not the same as in (a) above) of Registrable Securities Listed in Item (3) below: 

 

	 	(c)	Full Legal Name of DTC Participant (if applicable and if not the same as (b) above) Through Which Registrable Securities Listed in Item (3) below are Held:

  

	 	2.	Address for Notices to Selling Securityholder: 

  

	
	  

 
  
 

 

			
	 Telephone:
	 	  

			
	 Fax:
	 	
 

			
	 Contact Person:
	 	  

		 	

  

	 	3.	Beneficial Ownership of Securities: 

 Except as set forth below in this Item (3), the undersigned does not beneficially own any Securities. 
  

			
	(a)	  	Principal amount of Registrable Securities beneficially owned:
                                
		  	CUSIP No(s). of such Registrable Securities:
		  	  

		
	(b)	  	Principal amount of Securities other than Registrable Securities beneficially
owned:                                
		  	CUSIP No(s). of such other Securities:
		  	  

  
 A-4

			
	(c)	  	Principal amount of Registrable Securities which the undersigned wishes to be included in the Shelf Registration
Statement:                     
		  	CUSIP No(s). of such Registrable Securities to be included in the Shelf Registration Statement:

  

	 	4.	Beneficial Ownership of Other Securities of the Company: 

 Except as set forth below in this Item (4), the undersigned Selling Securityholder is not the beneficial or registered owner of any other securities of the Company, other than the Securities listed above
in Item (3). 
 State any exceptions here: 
  

	 	5.	Relationships with the Company: 

Except as set forth below, neither the Selling Securityholder nor any of its affiliates, officers, directors or principal equity holders
(5% or more) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years. 
 State any exceptions here: 
  

	 	6.	Plan of Distribution: 

 Except as
set forth below, the undersigned Selling Securityholder intends to distribute the Registrable Securities listed above in Item (3) only as follows (if at all): Such Registrable Securities may be sold from time to time directly by the undersigned
Selling Securityholder or, alternatively, through underwriters, broker-dealers or agents. Such Registrable Securities may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of sale, at varying prices
determined at the time of sale, or at negotiated prices. Such sales may be effected in transactions (which may involve crosses or block transactions) (i) on any national securities exchange or quotation service on which the Registered
Securities may be listed or quoted at the time of sale, (ii) in the over-the-counter market, (iii) in transactions otherwise than on such exchanges or services or in the over-the-counter market, or (iv) through the writing of options.
In connection with sales of the Registrable Securities or otherwise, the Selling Securityholder may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the Registrable Securities in the course of hedging
the positions they assume. The Selling Securityholder may also sell Registrable Securities short and deliver Registrable Securities to close out such short positions, or loan or pledge Registrable Securities to broker-dealers that in turn may sell
such securities. 
 State any exceptions here: 
 By signing below, the Selling Securityholder acknowledges that it understands its obligation to comply, and agrees that it will comply, with the provisions of the Exchange Act and the rules and
regulations thereunder, particularly Regulation M. 

  
 A-5

 In the event that the Selling Securityholder transfers all or any portion of the Registrable Securities
listed in Item (3) above after the date on which such information is provided to the Company, the Selling Securityholder agrees to notify the transferee(s) at the time of the transfer of its rights and obligations under this Notice and
Questionnaire and the Exchange and Registration Rights Agreement. 
 By signing below, the Selling Securityholder consents to the disclosure of
the information contained herein in its answers to Items (1) through (6) above and the inclusion of such information in the Shelf Registration Statement and related Prospectus. The Selling Securityholder understands that such information
will be relied upon by the Company in connection with the preparation of the Shelf Registration Statement and related Prospectus. 
 In
accordance with the Selling Securityholder’s obligation under Section 3(d) of the Exchange and Registration Rights Agreement to provide such information as may be required by law for inclusion in the Shelf Registration Statement, the
Selling Securityholder agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein which may occur subsequent to the date hereof at any time while the Shelf Registration Statement remains in effect. All
notices hereunder and pursuant to the Exchange and Registration Rights Agreement shall be made in writing, by hand delivery, first-class mail, or air courier guaranteeing overnight delivery as follows: 

 

	 	(i)	To the Company: 

US Foods, Inc. 
 9399 West Higgins Road, Suite 500 
 Rosemont, Illinois 60018

 Attention: General Counsel 
  

	 	(ii)	With a copy to: 

Steven J. Slutzky, Esq. 
 Debevoise & Plimpton LLP 
 919 Third Avenue 

New York, New York 10022 
 Once this Notice and Questionnaire is executed by the Selling Securityholder and received by the Company’s counsel, the terms of this Notice and Questionnaire, and the representations and warranties
contained herein, shall be binding on, shall inure to the benefit of and shall be enforceable by the respective successors, heirs, personal representatives, and assigns of the Company and the Selling Securityholder (with respect to the Registrable
Securities beneficially owned by such Selling Securityholder and listed in Item (3) above). This Agreement shall be governed in all respects by the laws of the State of New York. 

  
 A-6

 IN WITNESS WHEREOF, the undersigned, by authority duly given, has caused this Notice and Questionnaire to be
executed and delivered either in person or by its duly authorized agent. 
 Dated: 

 

			
	  

	Selling Securityholder
	(Print/type full legal name of beneficial owner of Registrable Securities)
		
	By:	 	  

		 	Name:
		 	Title:

  
 A-7

 PLEASE RETURN THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE FOR RECEIPT ON OR BEFORE [DEADLINE FOR
RESPONSE] TO THE COMPANY’S COUNSEL AT: 
 Steven J. Slutzky, Esq. 

Debevoise & Plimpton LLP 

919 Third Avenue 
 New York, New York 10022 

  
 A-8

 Exhibit B 
 NOTICE OF TRANSFER PURSUANT TO REGISTRATION STATEMENT 
 [INSERT NAME OF INSTITUTION APPOINTED AS
TRUSTEE] 
 [Address] 
 [Address]

 Attn: [Department] 
  

	 	Re:	US Foods, Inc. (the “Company”) 

	 	    	8.5% Senior Notes due 2019 

 Dear Ladies and
Gentlemen: 
 Please be advised that
                                 has transferred
$             aggregate principal amount of the above-referenced Notes pursuant to an effective Registration Statement on Form
[            ] (File No. 333-             ) filed by the Company. 
 We hereby certify that the prospectus delivery requirements, if any, of the Securities Act of 1933, as amended, have been satisfied and that the above-named beneficial owner of the Notes is named as a
“Selling Holder” in the Prospectus dated                     or in supplements thereto, and that the aggregate principal amount of the
Notes transferred are the Notes listed in such Prospectus opposite such owner’s name. 
 Dated: 

 

			
	 Very truly yours,

	
	  

	 (Name)
	 	
		
	 By:
	 	  

		 	(Authorized Signature)

  
 B-1Stockholders Agreement of USF Holding Corp.

 Exhibit 10.1 
 EXECUTION COPY 
  

 
 STOCKHOLDERS AGREEMENT

 of 
 USF HOLDING CORP. 
 dated as of July 3, 2007 

 
  

 TABLE OF CONTENTS 

 

					
	 	  	Page	 
	 RECITALS
	  	 	1	  
		
	 ARTICLE I DEFINITIONS
	  	 	1	  
	 SECTION 1.1. Certain Defined Terms
	  	 	1	  
	 SECTION 1.2. Other Definitional Provisions
	  	 	9	  
		
	 ARTICLE II CORPORATE GOVERNANCE
	  	 	9	  
	 SECTION 2.1. Board Representation
	  	 	9	  
	 SECTION 2.2. Committees
	  	 	11	  
	 SECTION 2.3. Consultant
	  	 	11	  
	 SECTION 2.4. Change in CEO
	  	 	11	  
	 SECTION 2.5. Consent Rights
	  	 	12	  
	 SECTION 2.6. Available Financial Information
	  	 	16	  
	 SECTION 2.7. Access
	  	 	17	  
	 SECTION 2.8. Termination of Rights
	  	 	17	  
	 SECTION 2.9. Corporate Opportunities
	  	 	18	  
		
	 ARTICLE III TRANSFERS
	  	 	18	  
	 SECTION 3.1. Rights and Obligations of Transferees
	  	 	18	  
	 SECTION 3.2. Transfer Restrictions
	  	 	19	  
	 SECTION 3.3. Right of First Offer
	  	 	20	  
	 SECTION 3.4. Right of Co-Sale on Transfers by Stockholders
	  	 	21	  
	 SECTION 3.5. Drag Along Right
	  	 	22	  
	 SECTION 3.6. Initiation of Qualified IPO
	  	 	24	  
	 SECTION 3.7. Void Transfers
	  	 	25	  
		
	 ARTICLE IV EQUITY PURCHASE RIGHTS
	  	 	25	  
	 SECTION 4.1. Equity Purchase Rights
	  	 	25	  
		
	 ARTICLE V MISCELLANEOUS
	  	 	26	  
	 SECTION 5.1. Stockholder Indemnification; Reimbursement of Expenses
	  	 	26	  
	 SECTION 5.2. Termination
	  	 	28	  
	 SECTION 5.3. Amendments and Waivers
	  	 	28	  
	 SECTION 5.4. Successors, Assigns and Transferees
	  	 	28	  
	 SECTION 5.5. Legend
	  	 	29	  
	 SECTION 5.6. Notices
	  	 	29	  
	 SECTION 5.7. Further Assurances
	  	 	31	  
	 SECTION 5.8. Entire Agreement
	  	 	31	  
	 SECTION 5.9. Restrictions on Other Agreements; Bylaws
	  	 	31	  
	 SECTION 5.10. Delays or Omissions
	  	 	31	  
	 SECTION 5.11. Governing Law; Jurisdiction; Waiver of Jury Trial
	  	 	32	  
	 SECTION 5.12. Severability
	  	 	32	  
	 SECTION 5.13. Enforcement
	  	 	32	  
	 SECTION 5.14. Titles and Subtitles
	  	 	32	  

					
	 SECTION 5.15. No Recourse
	  	 	32	  
	 SECTION 5.16. Counterparts; Facsimile Signatures
	  	 	33	  

 Exhibits 
 Exhibit A — Assignment and Assumption Agreement 

 THIS STOCKHOLDERS AGREEMENT (this “Agreement”) is entered as of
July 3, 2007, among USF HOLDING CORP., a Delaware corporation (the “Company”), U.S. FOODSERVICE, INC., a Delaware Corporation (“USF Inc.”), and each of the stockholders of the Company whose name appears on the
signature pages hereof and any Person who becomes a party hereto pursuant to Section 3.1(b) (each, a “Stockholder” and collectively, the “Stockholders”). 

RECITALS 

WHEREAS, Restore Acquisition Corp., a Delaware corporation and wholly owned subsidiary of the Company (“Restore”), has
entered into that certain Stock Purchase Agreement, dated May 2, 2007 (the “Purchase Agreement”), by and between Restore, Ahold U.S.A., Inc. and Koninklijke Ahold N.V. (“Ahold”), pursuant to which Restore will acquire
all of the outstanding shares of common stock of U.S. Foodservice, a Delaware corporation (“USF”), and certain related trademarks described in the Purchase Agreement (the “Acquisition”); 

WHEREAS, immediately following the Acquisition, Restore will merge with and into USF and USF will be the surviving corporation of the
merger; and 
 WHEREAS, each of the Stockholders desires to promote the interests of the Company and the mutual interests of
Stockholders by establishing herein certain terms and conditions upon which the shares of Common Stock (as defined below) will be held, including provisions restricting the transfer of shares of Common Stock, and providing for certain other matters.

 NOW, THEREFORE, in consideration of the foregoing recitals and of the mutual promises hereinafter set forth, the Company and
the Stockholders hereby agree as follows: 
 ARTICLE I 
 DEFINITIONS 
  

 
 SECTION 1.1.
Certain Defined Terms. As used herein, the following terms shall have the following meanings: 
 “Acceptance
Notice” has the meaning assigned to such term in Section 3.3(b). 
 “Affiliate” means, with
respect to any Person, any other Person directly or indirectly controlling, controlled by or under common control with, such Person. 
 “Annual Budget” has the meaning assigned to such term in Section 2.6(a). 
 “Annual Financial Statements” has the meaning assigned to such term in Section 2.6(a). 

 “beneficial owner” or “beneficially own” has the meaning
given such term in Rule 13d-3 under the Exchange Act and a Person’s beneficial ownership of Common Stock or other Voting Securities of the Company shall be calculated in accordance with the provisions of such Rule; provided, however,
that for purposes of determining beneficial ownership, (i) a Person shall be deemed to be the beneficial owner of any security which may be acquired by such Person, whether within sixty (60) days or thereafter, upon the conversion,
exchange or exercise of any warrants, options, rights or other securities and (ii) no Person shall be deemed to beneficially own any security solely as a result of such Person’s execution of this Agreement. 

“Board” means the Board of Directors of the Company. 

“Business Day” means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by
law to be closed in the City of New York. 
 “Bylaws” means the Bylaws of the Company, as in effect on the date
hereof and as the same may be amended, supplemented or otherwise modified from time to time in accordance with the terms thereof, the terms of the Charter and the terms of this Agreement. 

“Capstone” means Capstone Consulting LLC. 
 “CD&R Investors” means Clayton, Dubilier & Rice Fund VII, L.P., Clayton, Dubilier & Rice Fund VII (Co-Investment), L.P., CD&R Parallel Fund VII, L.P., CDR USF
Co-Investor L.P., and CDR USF Co-Investor No. 2, L.P. 
 “CD&R” means Clayton, Dubilier & Rice, Inc.

 “CD&R Designee” means any Director designated by the CD&R Investors pursuant to Section 2.1(a)
of this Agreement. 
 “CEO” means the Chief Executive Officer of the Company in office from time to time.

 “CEO Designee” has the meaning assigned to such term in Section 2.1(a). 

“Chairman” has the meaning assigned to such term in Section 2.1(a). 

“Change of Control” means the first to occur of the following events after the closing date of the Acquisition:
(i) the sale of all or substantially all of the assets of the Company to any Person (or group of Persons acting in concert), other than to (x) the Investors or their respective Affiliates or (y) any employee benefit plan (or trust
forming a part thereof) maintained by the Company or its Affiliates or other Person of which a majority of its voting power or other equity securities is owned, directly or indirectly, by the Company (any Person described in the foregoing clauses
(x) or (y), an “Affiliated Person”); or (ii) a sale by the Company, any of the Investors or any of their respective Affiliates to a Person (or group of Persons acting in concert) of Common Stock, or a merger, consolidation
or similar transaction involving the Company, in any case, that results in more than 50% of the Common Stock of the Company (or any resulting company after a merger) being held by a Person (or group of Persons acting in concert) that does not
include an Affiliated Person; in any event, which results in the Investors and their respective Affiliates or such employee benefit plan ceasing to hold the ability to elect a majority of the members of the Board. 

  
 2 

 “Charter” means the Amended and Restated Certificate of Incorporation of
the Company, as in effect on the date hereof and as the same may be amended, supplemented or otherwise modified from time to time in accordance with the terms thereof and the terms of this Agreement. 

“Closing” means the closing of Acquisition pursuant to the Purchase Agreement. 

“Closing Date” means July 3, 2007. 
 “Common Stock” means the common stock, par value $0.01 per share, of the Company and any securities issued in respect thereof; or in substitution therefor, in connection with any stock
split, dividend or combination, or any reclassification, recapitalization, merger, consolidation, exchange or other similar reorganization. 
 “Company” has the meaning assigned to such term in the recitals. 

“Company Elected Shares” has the meaning assigned to such term in Section 3.3(b). 

“Company Group” means the Company and its Subsidiaries. 

“Company Competitor” means any Person that is primarily engaged in any business that directly or indirectly competes
with the business of the Company in the foodservice distribution business in the continental United States. 
 “Company
Opportunity” has the meaning assigned to such term in Section 2.9(a). 
 “Competing Bidder” has
the meaning assigned to such term in Section 2.9(a). 
 “Competitive Board Members” has the meaning
assigned to such term in Section 2.9(a). 
 “Consulting Agreements” means collectively (1) the Consulting
Agreement, dated as of the date hereof, by and between CD&R and the Company, and (ii) the Consulting Agreement, dated as of the date hereof, by and between KKR and the Company, in each case, as the same may be amended from time to time in
accordance with its terms and the terms of this Agreement. 
 “control” (including the terms
“controlling”, “controlled by” and “under common control with”), with respect to the relationship between or among two or more Persons, means the possession, directly or indirectly, of the power to direct
or cause the direction of the affairs or management of a Person, whether through the ownership of voting securities, as trustee or executor, by contract or otherwise. 
 “Co-Sale Participant” has the meaning assigned to such term in Section 3.4(a). 

  
 3 

 “Director” means any member of the Board. 

“Drag Along Notice” has the meaning assigned to such term in Section 3.5(e). 

“Drag Transaction” has the meaning assigned to such term in Section 3.5(a). 

“EBITDA” means earnings before interest, taxes, depreciation and amortization plus extraordinary charges approved by the
Compensation Committee, determined in accordance with GAAP. 
 “Equity Purchase Shares” has the meaning
assigned to such term in Section 4.1(a). 
 “Equity Securities” means any and all shares of Common Stock
of the Company, securities of the Company convertible into, or exchangeable or exercisable for, such shares, and options, warrants or other rights to acquire such shares. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. 

“Exempt Transaction” means any acquisition or disposition (whether through merger, consolidation or otherwise)
(i) which has a purchase price (including any assumed indebtedness and valuing any non-cash consideration at its Fair Market Value) of less than $25,000,0000 and (ii) which, together with all other Exempt Transactions after the Closing
Date has an aggregate purchase price of less than $50,000,000; provided that no transaction described herein with any Affiliate of any Stockholder shall constitute an Exempt Transaction. 

“Exercising Stockholder” has the meaning assigned to such term in Section 4.1(d). 

“Fair Market Value” means with respect to Common Stock (i) from and after the consummation of a Qualified IPO, the
average of the closing sale prices of shares on the stock exchange or national market on which the shares are principally trading for a period of 30 trading days ending on the date in question, or (ii) prior to the consummation of an Qualified
IPO, the fair market value of the shares as determined in good faith by the Board; and with respect to any other non-cash consideration, the fair market value of such non-cash consideration as determined in good faith by the Board. 

“Financing” means the financing arrangements entered into by the Company and/or any Subsidiary of the Company on the
Closing Date to finance the Acquisition. 
 “First Offer Price” has the meaning assigned to such term in
Section 3.3(a). 
 “Fully-Diluted Basis” with respect to Common Stock or Voting Securities means the
number of shares of Common Stock or Voting Securities, as the case may be, which are issued and outstanding or owned or held, as applicable, at the date of determination plus the number of shares of Common Stock or Voting Securities, as the case may
be, issuable pursuant to any securities (other than, in the case of Voting Securities, other Voting Securities that the 

  
 4 

 
initial Voting Securities are convertible into or exchangeable or exercisable for), warrants, rights or options then outstanding, convertible into or exchangeable or exercisable for (whether or
not subject to contingencies or passage of time, or both), Common Stock or Voting Securities, as the case may be. 

“GAAP” means generally accepted accounting principles, as in effect in the. United States of America from time to time.

 “Group” has the meaning assigned to such term in Section 13(d)(3) of the Exchange Act. 

“Indemnification Agreements” means collectively, (i) the Indemnification Agreement, dated as of the date hereof, by
and among the Company, CD&R and the CD&R Investors, and (ii) the Indemnification Agreement, dated as of the date hereof, by and among the Company, KKR and the KKR Investors, in each case, as the same may be amended from time to time in
accordance with its terms and the terms of this Agreement. 
 “Independent Director” means a Director who
qualifies as “independent” under Rules 303A.01 and 303A.02 of the New York Stock Exchange Listed Company Manual. 

“Initiating Stockholder” has the meaning assigned to such term in Section 3.5. 

“Investors” means the CD&R Investors and the KKR Investors. 

“IPO” means the initial public offering of Common Stock pursuant to an effective registration statement under the Securities
Act. 
 “Issuance Notice” has the meaning assigned to such term in Section 4.1(b). 

“KKR” means Kohlberg Kravis Roberts & Co., L.P. 

“KKR Designee” means any Director designated by the KKR Investors pursuant to Section 2.1(a) of this Agreement.

 “KKR Investors” means KKR 2006 Fund L.P., KKR PEI Investments, L.P., KKR Partners III, L.P. and OPERF
Co-Investment LLC. 
 “Litigation Allocation Agreement” means that certain Litigation Allocation Agreement,
dated as of the date hereof, by and among Ahold, US Foodservice and U.S. Foodservice, Inc. 
 “Losses” has the
meaning assigned to such term in Section 5.1. 
 “New Securities” means shares of Equity Securities of the
Company or any similar securities of any Subsidiary (the “Subsidiary Equity Securities”) other than (i) options to purchase Common Stock and shares of Common Stock issued to employees, officers or directors pursuant to any
stock option, employee stock purchase or similar equity-based plans (including the purchase of Common Stock by management stockholders following the Closing as part of a 

  
 5 

 
management offering made pursuant to Section 701 of the Securities Act or another exemption from registration under the Securities Act) approved by the Board and Common Stock issued upon
exercise of such options, (ii) the issuance of Reserved Employee Shares or (iii) Subsidiary Equity Securities issued to the Company or another Subsidiary of the Company. 

“Non-Purchasing Stockholder” has the meaning assigned to such term in Section 4.1(d). 

“Offer Notice” has the meaning assigned to such term in Section 3.3(a). 

“Offered Securities” has the meaning assigned to such term in Section 3.3(a). 

“Offering Holder” has the meaning assigned to such term in Section 3.3(a). 

“Original Shares” means when used in reference to any one or more Stockholders, the shares of Common Stock sold to such
Stockholders pursuant to a Subscription Agreement, or any shares or other securities which such shares of Common Stock may have been converted into or exchanged for in connection with any exchange, reclassification, dividend, distribution, stock
split, combination, subdivision, merger, spin-off, re-capitalization, re-organization or similar transaction. 

“Permitted Transferee” means an Affiliate (other than any “portfolio company” described below) of a
Stockholder; provided, however, that in both cases such Transferee shall agree in a writing in the form attached as Exhibit A hereto to be bound by and to comply with all applicable provisions of this Agreement; provided, further,
however, that in no event shall (A) the Company or any of its Subsidiaries, (B) any “portfolio company” (as such term is customarily used among institutional investors) of any Stockholder or any entity controlled by any
portfolio company of any Stockholder or (C) any Company Competitor (whether or not an Affiliate of the Transferring Stockholder) constitute a “Permitted Transferee”. 

“Person” means any individual, corporation, limited liability company, limited or general partnership, joint venture,
association, joint-stock company, trust, unincorporated organization, government or any agency or political subdivisions thereof or any Group comprised of two or more of the foregoing. 

“Pledged Shares” has the meaning assigned to such term in Section 3.2(d). 

“Principal Investors” means Clayton, Dubilier & Rice Fund VII, L.P. and KKR 2006 Fund L.P. 

“Pro Rata Portion” means: 
 (i) for the purposes of Article IV, with respect to any Stockholder, on any issuance date for New Securities, the number or amount of New Securities equal to the product of (i) the total number or
amount of New Securities to be issued by the Company on such date and (ii) the fraction determined by dividing (A) the number of shares of Common Stock beneficially owned by such Stockholder immediately prior to such issuance by
(B) the total number of shares of Common Stock outstanding on such date immediately prior to such issuance on a Fully-Diluted Basis; 

  
 6 

 (ii) for the purposes of Section 3.3, with respect to any ROFO
Recipient, with respect to any proposed Transfer of Offered Securities, on the applicable Transfer Date, the number or amount of Offered Securities equal to the product of (i) the total number or amount of Offered Securities to be offered to
the ROFO Recipients and (ii) the fraction determined by dividing (A) the number of shares of Common Stock beneficially owned by such ROFO Recipient by (B) the total number of shares of Common Stock beneficially owned by all of the
ROFO Recipients as of such date; and 
 (iii) for the purposes of Section 3.4, with respect to any Co-Sale
Participant, with respect to any proposed Transfer of Transferred Securities, on the applicable Transfer date, the number or amount of Transferred Securities equal to the product of (i) the total number or amount of Transferred Securities to be
Transferred to the proposed Transferee and (ii) the fraction determined by dividing (A) the number of shares of Common Stock beneficially owned by such Co-Sale Participant by (B) the total number of shares of Common Stock beneficially
owned by all of the Stockholders (other than the Transferring Stockholder) as of such date. 
 “Qualified TO”
means the initial public offering of Common Stock pursuant to an effective Registration Statement under the Securities Act with aggregate gross cash proceeds (without regard to any underwriting discount or commission) of at least $400,000,000.

 “Reeistration Rights Agreement” means the Registration Rights Agreement, dated as of the date hereof, among
the Company and each of the Stockholders, as the same may be amended from time to time in accordance with its terms and the terms of this Agreement. 
 “Repurchase” has the meaning assigned to such term in Section 2.5(a)(v). 
 “Required Directors” has the meaning assigned to such term in Section 2.5(a). 
 “Reserved Employee Shares” means options to purchase Common Stock (and shares of Common Stock issuable upon the exercise thereof) to employees, officers, directors or consultants pursuant
to any stock option, employee stock purchase or similar equity-based plans approved by the Board of Directors (as appropriately adjusted for any subsequent stock dividends, combinations, splits or the like), including the 2007 Stock Option Plan for
Key Employees of USF Holding Corp. and its Subsidiaries. 
 “ROFO Recipients” has the meaning assigned to such
term in Section 3.3(a). 
 “ROFO Recipient Notice” has the meaning assigned to such term in Section
3.3(b). 
 “Section 3.3 Non-Electing Shares” has the meaning assigned to such term in Section 3.3(c).

  
 7 

 “Section 3.4 Non-Electing Shares” has the meaning assigned to such term in
Section 3.4(a). 
 “Securities Act” means the Securities Act of 1933, as amended, and the rules and
regulations promulgated thereunder. 
 “Selling Stockholders” has the meaning assigned to such term in
Section 3.5(a). 
 “Stockholder” has the meaning set forth in the recitals. 

“Stockholder Designees” has the meaning assigned to such term in Section 2.1(a). 

“Stockholder Indemnitee” has the meaning assigned to such term in Section 5.1. 

“Subsidiary” means (i) any corporation of which a majority of the securities entitled to vote generally in the
election of directors thereof, at the time as of which any determination is being made, are owned by another entity, either directly or indirectly, and (ii) any joint venture, general or limited partnership, limited liability company or other
legal entity in which an entity is the record or beneficial owner, directly or indirectly, of a majority of the voting interests or the general partner. 
 “Subscription Agreements” means the share subscription agreements entered into on the date hereof between the Company and each of the Stockholders pursuant to which each of the
Stockholders has agreed to purchase from the Company shares of Common Stock. 
 “Transfer” means, directly or
indirectly, to sell, transfer, assign, pledge, encumber, hypothecate or similarly dispose of, either voluntarily or involuntarily, or to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer,
assignment, pledge, encumbrance, hypothecation or similar disposition of, any shares of Equity Securities beneficially owned by a Person or any interest in any shares of Equity Securities beneficially owned by a Person. In the event that any
Stockholder that is a corporation, partnership, limited liability company or other legal entity (other than an individual, trust or estate) ceases to be controlled by the Person controlling such Stockholder or a Permitted Transferee thereof, such
event shall be deemed to constitute a “Transfer” subject to the restrictions on Transfer contained or referenced herein. 
 “Transferee” means any Person to whom any Stockholder or any Transferee thereof Transfers Equity Securities of the Company in accordance with the terms hereof. 

“Transfer Notice” has the meaning assigned to such term in Section 3.4(a). 

“Transferred Securities” has the meaning assigned to such term in Section 3.4(a). 

“Transferring Stockholder” has the meaning assigned to such term in Section 3.4(a). 

“USF” has the meaning assigned to such term in the recitals. 

  
 8 

 “USF. Inc.” has the meaning assigned to such term in the recitals. 

“Voting Securities” means, at any time, shares of any class of Equity Securities of the Company, which are then entitled
to vote generally in the election of Directors. 
 SECTION 1.2. Other Definitional Provisions. (a) The words
“hereof,” “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement, and Article and Section
references are to this Agreement unless otherwise specified. 
 (b) The meanings given to terms defined herein shall be equally
applicable to both the singular and plural forms of such terms. 
 ARTICLE H 

CORPORATEGOVERNANCE 
 SECTION 2.1. Board Representation. (a) Effective as of the Closing, the Board shall be comprised of seven Directors of whom: 

(i) three shall be designees of the CD&R Investors (such Persons, the “CD&R Designees”), of
whom, subject to Section 2.4, one shall be designated Chairman of the Board (“Chairman”), provided that such designee shall be an operating partner of CD&R and who shall be entitled to be active in the day-to-day business
of the Company and consult with the CEO with respect thereto for so long as the CD&R Investors deem such consultation to be effective; 
 (ii) three shall be designees of the KKR Investors (such Persons, the “KKR Designees”, and, together with the CD&R Designees, the “Stockholder Designees”); and

 (iii) one designee shall be the CEO (the “CEO Designee”) who shall be designated jointly by
the CD&R Investors and the KKR Investors in accordance with Section 2.5(a). 
 Effective as of the
Closing, the CD&R Designees shall initially be Charles A. Banks, Richard J. Schnall and Nathan K. Sleeper, and Charles A. Banks shall initially be designated as Chairman, the KKR Designees shall initially be Robert G. Tobin, Michael M. Calbert
and Sanjay K. Morey, and the CEO Designee shall initially be Robert Aiken, Jr. 
 (b) The Company shall take such action as may
be required under applicable law to cause the Board to consist of the number of Directors specified in clause (a). 
 (c) The
Company agrees to include in the slate of nominees recommended by the Board the Stockholder Designees and the CEO Designee and to use its best efforts to cause the election of each such designee to the Board, including nominating such individuals to
be elected as Directors as provided herein. 

  
 9 

 (d) In the event that a vacancy is created at any time by the death, disability, retirement,
resignation or removal (with or without cause) of any Director designated pursuant to clause (i), (ii) or (iii) of Section 2.1(a), the remaining Directors and the Company shall cause the vacancy created thereby to be filled by a new
designee of the CD&R Investors or the KKR Investors, as applicable, who designated such Director as soon as possible, and the Company hereby agrees to take, at any time and from time to time, all actions necessary to accomplish the same.

 (e) Each of the Stockholders agrees to vote, or act by written consent with respect to, any Voting Securities beneficially
owned by it, at each annual or special meeting of stockholders of the Company at which Directors are to be elected or to take all actions by written consent in lieu of any such meeting as are necessary, to cause the Stockholder Designees and the CEO
Designee to be elected to the Board. Each of the Stockholders agrees to use its commercially reasonable efforts to cause the election of each such designee to the Board, including nominating such individuals to be elected as members of the Board. In
the event that a vacancy is created at any time by the death, disability, retirement, resignation or removal (with or without cause) of any Director designated pursuant to clause (i), (ii) or (iii) of Section 2.1(a) and the remaining
Directors pursuant to Section 2.1(d) have caused the vacancy created thereby to be filled by a new designee of the CD&R Investors or KKR Investors, as applicable, then in such case each Stockholder hereby agrees to take, at any time and
from time to time, all actions necessary to accomplish the same. Upon the written request of the CD&R Investors or the KKR Investors, as applicable, each other Stockholder shall vote, or act by written consent with respect to, all Voting
Securities beneficially owned by it and otherwise take or cause to be taken all actions necessary to remove any Director designated by such Stockholders and to elect any replacement Director designated as provided in this Section 2.1(e). Unless
the CD&R Investors or the KKR Investors shall otherwise request in writing, no other Stockholder shall take any action to cause the removal of any Directors designated by such Stockholders. 

(f) In the event the CD&R Investors or the KKR Investors, as applicable, shall cease to have the right to designate a Director in
accordance with Section 2.8, the designee of such Stockholders selected by such Stockholders shall resign and the Directors remaining in office shall decrease the size of the Board to eliminate such vacancy and no consent under
Section 2.5(a) shall be required in connection with such decrease. 
 (g) The Company shall reimburse each Stockholder
Designee for their reasonable out-of-pocket expenses incurred by them for the purpose of attending meetings of the Board or committees thereof. 
 (h) The CD&R Investors and the KKR Investors shall have the right to equal representation on the board of directors of any Subsidiary in proportion to their representation on the Board. 

(i) Following any termination or resignation of the CEO and prior to the hiring of a replacement CEO pursuant to Section 2.4(c), the
CD&R Designee serving as Chairman pursuant to Section 2.1(a)(i) shall be entitled to serve also as CEO on an interim basis until such replacement CEO is hired (during which time the Board seat to which the CEO Designee is entitled pursuant
to Section 2.1(a)(iii) shall remain vacant). In the event that such CD&R Designee has served as CEO for a period of six months, the continuation of such CD&R Designee to serve in such position shall require the approval of the Required
Directors pursuant to Section 2.5(a)(i). 

  
 10 

 (j) In the event that the size of the Board is expanded to include Independent Directors,
the CD&R Investors, on the one hand, and the KKR Investors, on the other hand, shall initially be entitled to designate an equal number of Independent Directors and each such Independent Director shall be subject to the approval of the
non-designating Investor. 
 (k) The rights of the Stockholders pursuant to this Section 2.1 are personal to the
Stockholders and shall not be exercised by any Transferee other than a Permitted Transferee described in clause (ii) of the definition thereof. 
 SECTION 2.2. Committees. (a) The Board shall establish an Executive Committee and a Compensation Committee, the power and authority of each to be determined from time to time by the Board with
the approval of the Required Directors. So long as a CD&R Designee is designated Chairman, subject to Section 2.4, the Chairman of the Executive Committee (or any committee performing the functions usually reserved for the executive
committee) shall be a KKR Designee. So long as the CD&R Designee designated as Chairman is active in the day-to-day business of the Company (whether or not such designee at such time is serving as Chairman), the Chairman of the Compensation
Committee (or any committee performing the functions usually reserved for the compensation committee) shall be a KKR Designee. As of the Closing, Michael M. Calbert shall initially be the Chairman of the Executive Committee and the Compensation
Committee. 
 (b) So long as the CD&R Investors or the KKR Investors, as applicable, have the right to designate at least
one (1) Director pursuant to Section 2.1, the Company shall cause the Executive Committee, Compensation Committee, audit committee or other significant committee of the Board (including, without limitation, any committee performing the
functions usually reserved for the committees described above) to include at least one (1) CD&R Designee and one (1) KKR Designee; provided that the composition of each such committee shall reflect the relative number of
Stockholder Designees for the CD&R Investors, on the one hand, and the KKR Investors, on the other hand. 
 SECTION 2.3.
Consultant. So long as the CD&R Designee designated as Chairman is active in the day-to-day business of the Company, and the KKR Investors determine in good faith that its engagement will add value to the projects of the Company, Capstone
shall be engaged by the Company to work on such projects. Capstone shall not be terminated by the Company without the prior written consent of the KKR Investors. The Company shall enter into a customary consulting agreement with Capstone for such
services, which agreement shall provide that Capstone will be compensated by the Company at market rates prevailing from time to time for such services. 
 SECTION 2.4. Change in CEO. (a) The Principal Investors shall cooperate with each other in good faith to evaluate on a periodic basis the performance of the CEO and shall use all reasonable
efforts to reach mutual agreement with respect to whether replacing the CEO at any time is in the best interests of the Company. 

  
 11 

 (b) In the event that, with respect to any full fiscal year period, the EBITDA of the
Company is more than 10% less than the target EBITDA established for such fiscal year as set forth in the applicable Annual Budget approved pursuant to Section 2.5, the Principal Investors shall engage in good faith discussions regarding the
replacement of the CEO promptly following receipt of the Annual Financial Statements with respect to such fiscal year. In the event that the Principal Investors are unable to reach agreement with respect to such decision within 30 days following
receipt of such Annual Financial Statements, at any time during the subsequent 90-day period, each of the Principal Investors, shall be permitted to cause the termination and replacement of the CEO without the consent of the Required Directors, and
if such Principal Investor notifies the other Principal Investor that it intends to exercise its rights hereunder to cause such termination, such other Principal Investor shall use its reasonable best efforts to cooperate to cause such termination,
including, without limitation, causing its designees on the Board to take any action required to effect such termination. 
 (c)
Following any termination or resignation of the CEO, the Stockholder Designees shall cause the Board to promptly initiate a search for a replacement CEO, the hiring of such replacement CEO to require the consent of the Required Directors pursuant to
Section 2.5(a)(i). In connection with such search, the Principal Investors shall consider in good faith the need to combine the titles of Chairman and CEO to the extent necessary to attract the most qualified CEO candidates. In the event the title
of Chairman is awarded to any replacement CEO, the CD&R Designee entitled to such position pursuant to Section 2.1(a)(i) shall relinquish such right and shall instead (subject to the consent of the KKR Investors and the CD&R Investors)
be appointed as Chairman of the Executive Committee of the Board, in each case until such time as the CEO no longer holds such title or is otherwise terminated or resigns. Upon the termination or resignation of any Person who holds the title of
Chairman and CEO, the CD&R Designee shall be entitled to serve as both Chairman pursuant to Section 2.1(a)(i) and interim CEO pursuant to Section 2.1(i)). Notwithstanding that such CD&R Designee no longer holds the title of
Chairman, such designee shall be entitled to continue to be active in the day-to-day business of the Company as specified in Section 2.1(a)(i). 
 SECTION 2.5. Consent Rights. (a) In addition to any vote or consent of the Board or the stockholders of the Company required by law or the Charter, and notwithstanding anything in this
Agreement to the contrary, the Company shall not, and to the extent applicable, shall not permit any Subsidiary of the Company to, take any of the following actions, or enter into any arrangement or contract to do any of the following actions,
without the consent in writing of at least one CD&R Designee and one KKR Designee (the consent of the “Required Directors”), which shall be necessary for authorizing, effecting or validating such transactions; provided
that if the CD&R Investors or the KKR Investors, as applicable, are no longer entitled to appoint a Stockholder Designee, any such action shall, subject to Section 2.8(a), require the written consent of the CD&R Investors or the KKR
Investors, as applicable: 
 (i) except as provided in Section 2.4, the selection, hiring, termination or
removal of the CEO, any Person hired to replace the CEO, the continuation of a CD&R Designee as interim CEO for a period of greater than six months, and any determination of the compensation of the CEO of the Company or his or her direct
reports; 

  
 12 

 (ii) any (A) merger or consolidation with or into any other Person, or
any acquisition of another Person, whether in a single transaction or a series of related transactions, other than any Exempt Transaction, (B) proposed transaction or series of related transactions involving a Change of Control of the Company
(including for the avoidance of doubt, a Change of Control resulting from a Drag Transaction), or (C) proposed Transfer by a Stockholder except to a Permitted Transferee or as permitted by Section 3.2 hereof; 

(iii) the incurrence of indebtedness for borrowed money (including through capital leases, the issuance of debt securities
or the guarantee of indebtedness of another Person) other than (A) the incurrence of trade payables arising in the ordinary course of operating the business, (B) the incurrence of indebtedness under debt facilities entered into in
connection with the Acquisition not to exceed $100 million in the aggregate or (C) capital leases contemplated by an Annual Budget approved pursuant to clause (xvii) of this Section 2.5(a); 

(iv) any authorization, creation (by way of reclassification, merger, consolidation or otherwise) or issuance of any
securities of the Company (including any IPO (other than any IPO initiated pursuant to Section 3.6) and for the avoidance of doubt, in connection with an Exempt Transaction), other than (A) the issuance of Reserved Employee Shares, or
(B) the issuance of any securities as consideration in, or in connection with, a transaction approved pursuant to Sections 2.5(a) (ii) or (xiii); 
 (v) any redemption, acquisition or other purchase of any shares of Common Stock (a “Repurchase”) other than a Repurchase from an employee (not including the CEO) in connection with such
employee's termination of employment with the Company or any Subsidiary; 
 (vi) any payment or declaration of
any dividend or other distribution on any shares of Common Stock or entering into any recapitalization transaction the primary purpose of which is to pay a dividend; 

(vii) the creation of any non-wholly owned subsidiaries, or the Transfer or any sale or Transfer of a Subsidiary’s
securities to any Person other than the Company or a wholly owned Subsidiary of the Company (other than any pledge of such Subsidiary’s stock pursuant to a financing approved by the Board in accordance with Section 2 .5 (a)(iii);

 (viii) the creation or amendment of any stock option, employee stock purchase or similar equity-based plan for
management or employees, or any increase in the number of Reserved Employee Shares; 
 (ix) any amendment,
modification or waiver of any provision contained in the Purchase Agreement or the Litigation Allocation Agreement; 

  
 13 

 (x) any transaction with or involving any Affiliate of the Company or any
Affiliate of any stockholder of the Company that beneficially owns in excess of ten percent (10%) of the voting power of the Company, other than (A) a Transfer to a 
 Permitted Transferee, (B) the Consulting Agreements, the Registration Rights Agreement, the Indemnification Agreements, and the Subscription Agreements, but including any amendment, termination or
material waiver under any such agreements, (C) any transaction or series of related transactions in the ordinary course of business and on arms-length third-party terms with any “portfolio company” (as such term is customarily used
among institutional investors) held or managed by any Affiliate of the Company and not involving amounts in excess of $5,000,000 million per annum or (D) any transaction or series of related transactions with Capstone contemplated by
Section 2.3; 
 (xi) any amendment, repeal or alteration of the Charter or the Bylaws or any
organizational documents of any Subsidiary, whether by or in connection with a merger or consolidation or otherwise; 
 (xii) any increase or decrease in the size or composition of the Board, committees of the Board, and boards and committees of Subsidiaries of the Company and any termination or removal of an independent
Director; 
 (xiii) any (A) acquisition of the stock or assets of any Person, or the acquiring by any other
manner of any business, properties, assets, or Persons, in one transaction or a series of related transactions, or (B) dispositions of assets of the Company or any Subsidiary, other than, in either case, an Exempt Transaction; 

(xiv) [intentionally omitted]; 
 (xv) any voluntary election by the Company or any Subsidiary of the Company to liquidate or dissolve or to commence bankruptcy or insolvency proceedings or the adoption of a plan with respect to any of
the foregoing; 
 (xvi) any material change in a significant accounting policy of the Company and any termination
or change of the Company’s independent auditor; 
 (xvii) approval of the Annual Budget (as defined in
Section 2.6(a)(ii)); 
 (xviii) following the Closing, any amendment to, or granting of any waiver under,
the Purchase Agreement or any agreement entered into in connection with the Financing, in each case, in a manner materially adverse to the Company or any Subsidiary of the Company or that would adversely affect any Investor disproportionately when
compared to the other Investor; 
 (xix) until the sixth anniversary of the Closing Date, the commencement of an
IPO; 
 (xx) the grant of registration rights to any Stockholder (including any Permitted Transferee of a
Stockholder), other than (A) the transfer of demand registration rights permitted by the Registration Rights Agreement or (B) the grant of piggyback registration rights pursuant to any agreement entered into with any management stockholder
after the date hereof in the ordinary course; 

  
 14 

 (xxi) following an IPO, the deregistration of the Company pursuant to
Section 7 of the Registration Rights Agreement; 
 (xxii) settlement of any litigation to which the Company
or any of its Subsidiaries is a party involving the payment by the Company or any of its Subsidiaries of an amount equal to or greater than $15 million; 
 (xxiii) making a material tax election or entering into any agreement in respect of taxes, including the settlement of any material tax controversy, or similar action relating to the filing of any tax
return or the payment of any tax, if such election, agreement or action would reasonably be expected to result in any direct tax liability for any of the Stockholders or any direct or indirect holder of equity in any of the Stockholders; and

 (xxiv) any material change in the nature of the business of the Company or any Subsidiary, taken as a whole.

 (b) In connection with any vote or action by written consent of the stockholders of the Company relating to any matter
requiring consent as specified in Section 2.5(a), each Stockholder agrees, with respect to any Voting Securities beneficially owned by such Stockholder with respect to which it has the power to vote, (i) to vote against (and not act by
written consent to approve) such matter if such matter has not been consented to by the Required Directors in accordance with Section 2.5(a) and (ii) to take or cause to be taken, upon the written request of the CD&R Investors
(if such matter has not been consented to by a CD&R Designee) or the KKR Investors (if such matter has not been consented to by a KKR Designee), all other reasonable actions, at the expense of the Company, required, to the extent permitted by
law, to prevent the taking of any action by the Company with respect to a matter unless such matter has been consented to by the Required Directors in accordance with Section 2.5(a). 

(c) Each Stockholder (i) that is a Permitted Transferee, an Affiliate co-investor or a co-investment vehicle hereby irrevocably
grants to and appoints the Principal Investor which is an Affiliate of such Stockholder and (ii) that is not a Person described in clause (i), hereby irrevocably grants to and appoints the Principal Investors collectively (to act by unanimous
consent) such Stockholder’s proxy and attorney-in-fact (with full power of substitution), for and in the name, place and stead of such Stockholder, to vote or act by written consent with respect to such Stockholder's Common Stock, and to grant
a consent, proxy or approval in respect of such Common Stock, in the event that such Stockholder fails at any time to vote or act by written consent with respect to any of its Common Stock in the manner agreed by such Stockholder in this Agreement,
in each case in accordance with such Stockholder's agreements contained in this Agreement. Each Stockholder (other than the Principal Investors) hereby affirms that the irrevocable proxy set forth in this Section 2.5(c) will be valid for the
term of this Agreement and is given to secure the performance of the obligations of such Stockholder under this Agreement. Each such Stockholder hereby further affirms that each proxy hereby granted shall be irrevocable and shall be deemed coupled
with an interest and shall extend for the term of this Agreement, or, if earlier, until the last date permitted by applicable law. For the avoidance of doubt, except as expressly contemplated by this Section 2.5(c), none of the Stockholders has
been granted a proxy to any Person to exercise the rights of any such Stockholder under this Agreement or any other agreement to which such Stockholders is a party. 

  
 15 

 SECTION 2.6. Available Financial Information. (a) The Company will deliver, or
will cause to be delivered, the information set forth in clauses (iii) and (iv) to each Stockholder and the information listed in clause (i) and (ii) to the Principal Investors and any transferee of a CD&R Investor or a KKR
Investor which holds shares of Common Stock that constitute at least 25% of the Original Shares of the CD&R Investors or the KKR Investors, until such time as such Stockholder and its Affiliates shall cease to own any shares of Common Stock:

 (i) as soon as available after the end of each month and in any event within thirty (30) days
thereafter, a consolidated balance sheet of the Company and its Subsidiaries as of the end of such month and consolidated statements of operations, income, cash flows, retained earnings and stockholders' equity of the Company and its Subsidiaries,
for each month and for the current fiscal year of the Company to date, prepared in accordance with GAAP (subject to normal year-end audit adjustments and the absence of notes thereto), together with a comparison of such statements to the
corresponding periods of the prior fiscal year and to the Company's business plan then in effect and approved by the Board; 
 (ii) an annual budget, a business plan and financial forecasts for the Company for the next fiscal year of the Company (the “Annual Budget”), no later than thirty (30) days before
the beginning of the Company's next fiscal year, in such manner and form as approved by the Board, which shall include at least a projection of income and a projected cash flow statement for each fiscal quarter in such fiscal year and a projected
balance sheet as of the end of each fiscal quarter in such fiscal year, in each case prepared in reasonable detail, with appropriate presentation and discussion of the principal assumptions upon which such budgets and projections are based, which
shall be accompanied by the statement of the chief executive officer or chief financial officer or equivalent officer of the Company to the effect that such budget and projections are based on reasonable and good faith estimates and assumptions made
by the management of the Company for the respective periods covered thereby; it being recognized by such holders that such budgets and projections as to future events are not to be viewed as facts and that actual results during the period or periods
covered by them may differ from the projected results. Any material changes in such Annual Budget shall be delivered to the Stockholders as promptly as practicable after such changes have been approved by the Board; 

(iii) as soon as available after the end of each fiscal year of the Company, and in any event within ninety (90) days
thereafter, (A) the annual financial statements required to be filed by the Company pursuant to the Exchange Act or (B) a consolidated balance sheet of the Company and its Subsidiaries as of the end of such fiscal year, and consolidated
statements of income, retained earnings and cash flows of the Company and its Subsidiaries for such year, prepared in accordance with GAAP and setting forth in each case in comparative form the figures for the previous fiscal year, all in reasonable
detail and accompanied by the opinion of independent public accountants of recognized national standing selected by the Company, and a Company-prepared comparison to the Company's Annual Budget for such year as approved by the Board (the
“Annual Financial Statements”); and 

  
 16 

 (iv) as soon as available after the end of the first, second and third
quarterly accounting periods in each fiscal year of the Company, and in any event within forty-five (45) days thereafter, (A) the quarterly financial statements required to be filed by the Company pursuant to the Exchange Act or (B) a
consolidated balance sheet of the Company and its Subsidiaries as of the end of each such quarterly period, and consolidated statements of income, retained earnings and cash flows of the Company and its Subsidiaries for such period and for the
current fiscal year to date, prepared in accordance with GAAP (subject to normal year-end audit adjustments and the absence of notes thereto) and setting forth in comparative form the figures for the corresponding periods of the previous fiscal year
and to the Company's Annual Budget then in effect as approved by the Board, all in reasonable detail and certified by the principal financial or accounting officer of the Company. 

(b) Other Information. The Company covenants and agrees to deliver to each Stockholder until such time as such Stockholder shall
cease to own any shares of Common Stock, with reasonable promptness, such other information and data (including such information and reports made available to any lender of the Company or any of its Subsidiaries under any credit agreement or
otherwise) with respect to the Company and each of its Subsidiaries as from time to time may be reasonably requested by any such Stockholder. 
 SECTION 2.7. Access. The Company shall, and shall cause its Subsidiaries, officers, directors, employees, auditors and other agents to, until such time as an Stockholder shall cease to own any
shares of Common Stock, (a) afford the officers, employees, auditors and other agents of such Stockholder, during normal business hours and upon reasonable notice reasonable access at all reasonable times to its officers, employees, auditors,
legal counsel, properties, offices, plants and other facilities and to all books and records, and (b) afford such Stockholder the opportunity to discuss the affairs, finances and accounts of the Company and its Subsidiaries with their
respective officers from time to time as each such Stockholder may reasonably request. 
 SECTION 2.8. Termination of
Rights. (a) Notwithstanding Sections 2.4 and 2.5, at such time as the CD&R Investors or the KKR Investors, as applicable, together with their respective Affiliates, shall cease to own a number of shares of Common Stock equal to at least
ten percent (10%) of the outstanding shares of Common Stock, the CD&R Investors or the KKR Investors, as applicable, shall cease to have any rights under Sections 2.4 and 2.5; 

(b) Notwithstanding Section 2.1, at such time as the CD&R Investors or the KKR Investors, as applicable, together with its
respective Affiliates, shall cease to own a number of shares of Common Stock equal to at least seventy-five percent (75%) of its Original Shares, the CD&R Investors or the KKR Investors, as applicable, shall cease to have the right to
designate more than two Directors pursuant to Section 2.1. 
 (c) Notwithstanding Section 2.1, at such time as the
CD&R Investors or the KKR Investors, as applicable, together with its respective Affiliates, shall cease to own a number of shares of Common Stock equal to at least fifty percent (50%) of its Original Shares, the CD&R Investors or the
KKR Investors, as applicable, shall cease to have the right to designate more than one Director pursuant to Section 2.1. 

  
 17 

 (d) Notwithstanding Section 2.1, at such time as the CD&R Investors or the KKR
Investors, as applicable, together with their respective Affiliates, shall cease to own a number of shares of Common Stock equal to at least fifteen percent (15%) of its Original Shares, the CD&R Investors or the KKR Investors, as
applicable, shall cease to have the right to designate any Directors pursuant to Section 2.1 and any rights or obligations pursuant to Sections 2.2 and 2.9 (other than the obligation set forth in the last sentence of Section 2.9 to keep
confidential any information regarding any Company Opportunity, which shall continue for period of two years thereafter); 

SECTION 2.9. Corporate Opportunities. 
 (a) Each Stockholder shall cause its Stockholder Designees to recuse themselves from all deliberations of the Board, and the Company shall have no obligation to provide to such Stockholder Designees any
information, regarding any acquisition, disposition, investment or similar transaction that the Company elects to pursue (a “Company Opportunity”) if such • Stockholder or its Affiliates that are under common control with such
Stockholder has or is entitled to designate one or more individuals to serve on the board of directors or body serving a similar function (such individuals being referred to as “Competitive Board Members”) of any other Person who is
competing with or that is otherwise adverse to the Company with respect to such acquisition, disposition, investment or similar transaction (such an other Person being referred to as a “Competing Bidder”); provided, however, that
such Stockholder shall not be so obligated to cause its Stockholder Designees to so recuse themselves from such deliberations of the Board, and its Stockholder Designees shall continue to be entitled to receive all information made available to all
Directors regarding any Company Opportunity, if such Stockholder causes such Competitor Board Members (if any shall be in place) of the Competing Bidder to recuse themselves from all deliberations of the Competing Bidder with respect to such Company
Opportunity. In addition, each of the Stockholders shall, and shall cause its Stockholder Designees to, keep confidential any information regarding any Company Opportunity, including the existence of such potential acquisition, disposition,
investment or similar transaction, that any such Stockholder or Stockholder Designee learns about as a result of its participation in the Board. 
 ARTICLE III 
 TRANSFERS 

SECTION 3.1. Rights and Obligations of Transferees. (a) Except with the prior written consent of the Required Directors
pursuant to clause (xiii) of Section 2.5(a) (and if none of the Stockholders is entitled to designate any Directors pursuant to Section 2.1 then the prior written consent of a majority of the Board), no Transferee of any Stockholder,
except a Permitted Transferee shall be entitled to any rights under this Agreement other than the right of co-sale set forth in Section 3.4. 
 (b) Subject to the last sentence of this Section 3.1(b), prior to the consummation of a Transfer by any Stockholder or any Transferee, as a condition thereto, the applicable Transferee or subsequent
Transferee shall agree in writing in the form attached as Exhibit A 

  
 18 

 hereto to assume all of the obligations in this Agreement applicable to the Transferring Stockholder.
Notwithstanding the foregoing, a Transferee of Equity Securities shall not be bound by any of the terms and conditions of this Agreement if the applicable Transfer is pursuant to an effective registration statement under the Securities Act or
pursuant to Rule 144 of the Securities Act. 
 SECTION 3.2. Transfer Restrictions. (a) Until the sixth anniversary
of the Closing Date, each Stockholder hereby agrees that such Stockholder shall not Transfer any of its Equity Securities at any time other than (i) Transfers of its Equity Securities to its Permitted Transferees, (ii) following a
Qualified IPO (subject to applicable and customary underwriter restrictions), Transfers pursuant to the Registration Rights Agreement, and (iii) with the prior written consent of the Required Directors pursuant to clause (ii) of
Section 2.5(a) (and if none of the Stockholders is entitled to designate any Directors pursuant to Section 2.1 then the prior written consent of a majority of the Board) and subject to compliance with the provisions of Section 3.4
(and any such sale pursuant rights granted to Co-Sale Participants (as defined therein) under Section 3.4 shall not be prohibited hereby). 
 (b) Following the sixth anniversary of the Closing Date, if the Company has not completed a Qualified IPO, each Stockholder may freely Transfer its Equity Securities without restriction subject to
compliance with Sections 3.3 and 3.4 (except in connection with Section 3.6), provided however that, under no circumstances shall any Stockholder have the right to Transfer any of its Equity Securities to a Company Competitor. 

(c) Following the sixth anniversary of the Closing Date, if the Company has completed a Qualified IPO (subject to applicable and
customary underwriter restrictions), each Stockholder may freely Transfer its Equity Securities without restriction subject to compliance with applicable securities laws and pursuant to the Registration Rights Agreement. 

(d) Notwithstanding the provisions of Section 3.2, each of the CD&R Investors (taken as a whole) and the KKR Investors (taken as
a whole) shall have the right to pledge up to 20,000,000 shares of Common Stock (subject to adjustment for any stock splits, combination and the like) (the “Pledged Shares”) pursuant to a bona fide financing transaction;
provided that any agreement entered into with a lender in connection with such pledge will provide that (i) in the event such lender seeks to enforce such pledge, prior to such lender commencing any foreclosure action with respect to the
Pledged Shares, the Principal Investors and/or their designees (provided that any such designee shall be an Affiliate of such Investor and shall hold more than 15% of the outstanding shares of Common Stock) shall have the right to acquire pursuant
to a pro rata right of first offer the Pledged Shares subject to the lender's pledge; (ii) if the Investors have not elected to purchase all of the Pledged Shares, the lender, subject to any consent applicable to Transfers to a third party
under the transfer restrictions contained in this Agreement, including Section 2.5(a)(ii) hereof, shall have the right to foreclose upon any Pledged Shares as to which the Investors and/or their designees have not exercised their pro rata right
of first offer as contemplated by clause (i) above and (iii) upon such foreclosure, the lender shall adhere to all of the obligations under this Agreement (including, without limitation, the transfer restrictions set forth herein). The
agreement entered into with the lender with respect to the Pledged Shares shall also provide that notwithstanding any other provisions of this Agreement to the contrary, (i) the lender shall only receive pro rata co- sale rights pursuant

  
 19 

 to Section 3.4 of this Agreement and (ii) for the avoidance of doubt, upon foreclosure by the
lender on any Pledged Shares, such shares will automatically convert to non-voting shares and the lender will not have any right to appoint or designate members of the Board or any of the Company's Subsidiaries or Affiliates or any other governance,
consent or approval rights. 
 (e) Each Stockholder shall as promptly as practicable provide the Stockholders and the Company
with written notice of any Transfer made in accordance with Section 3.2(a), (b) or (d). 
 SECTION 3.3. Right of
First Offer. Following the sixth anniversary of the Closing Date, so long as the Company has not completed a Qualified IPO, no Stockholder shall Transfer any of its Equity Securities other than to a Permitted Transferee except as set forth
below: 
 (a) Prior to any Transfer of Equity Securities by a Stockholder (the “Offering Holder”), the Offering
Holder shall deliver to the Company and each other Stockholder that is not an Affiliate of the Offering Holder (collectively, excluding the Company, the “ROFO Recipients”) written notice (the “Offer Notice”),
stating such Offering Holder's intention to effect such a Transfer, the number of Equity Securities subject to such Transfer (the “Offered Securities”), the price the Offering Holder proposes to be paid for the Offered Securities
(the “First Offer Price”), and the other material terms and conditions of the proposed Transfer. The Offer Notice may require that the consummation of any sale of the Offered Securities to the Company or the ROFO Recipients occur no
less than 15 days, and no later than 60 days, after the date of the Offer Notice. 
 (b) Upon receipt of the Offer Notice, the
Company will have an irrevocable non-transferable option to purchase all or a portion of the Offered Securities at the First Offer Price and otherwise on the terms and conditions described in the Offer Notice (the “First Offer”).
The Company shall, within 15 days from receipt of the Offer Notice, indicate whether or not it has accepted the First Offer by sending irrevocable written notice (the “Acceptance Notice”) of any such acceptance to the
Offering Holder and the ROFO Recipients indicating the number of Offered Shares to be purchased (the “Company Elected Shares”), and the Company shall then be obligated to purchase such Company Elected Shares on the terms and
conditions set forth in the Offer Notice. In the event the Company elects not to purchase any or all of the Offered Securities, the ROFO Recipients shall have the right to purchase a number of shares equal to such ROFO Recipient's Pro Rata Portion
of the Offered Securities other than the Company Elected Shares, if any. Each of the ROFO Recipients shall, within 15 days from receipt of the Company's Acceptance Notice, send an irrevocable written notice (the “ROFO Recipient
Notice”) to the Offering Holder and the Company if it has accepted the First Offer and, if so, the portion of such ROFO Recipient's Pro Rata Portion that it will purchase. The ROFO Recipient shall then be obligated to purchase such number of
Offered Securities set forth in such ROFO Recipient Notice on the terms and conditions set forth in the Offer Notice. 
 (c) In
the event any ROFO Recipient elects to purchase less than all of its Pro Rata Portion of the Offered Securities minus the Company Elected Shares, if any, (such remaining securities, the “Section 3.3 Non-Electing Shares”), each other
ROFO Recipient shall be entitled to purchase its Pro Rata Portion of the Section 3.3 Non-Electing Shares. Any ROFO 

  
 20 

 Recipient who wishes to exercise its rights under this Section 3.3(c) shall send a notice setting forth
its irrevocable intent to purchase its Pro Rata Portion of the Section 3.3 Non-Electing Shares to the Offering Holder and the Company. After receipt of notice from each such ROFO Recipient electing to exercise its right of first offer, the
Company shall determine the number of Offered Securities (taking into account all of the Offered Securities being purchased by the Company and each other ROFO Recipient pursuant to this Section 3.3) which each such ROFO Recipient shall be
entitled to purchase pursuant to this Section 3.3(c) and each such ROFO Recipient shall be required to purchase the number of Offered Securities as so determined. 
 (d) If following the procedures set forth in paragraphs (b) and (c), neither the Company nor the ROFO Recipients (in the aggregate) have elected to purchase all of the Offered Securities pursuant to
this Section 3.3, then the applicable Offering Holder shall be free for a period of six months from the date acceptance notices from the ROFO Recipients were due to be received by the applicable Offering Holder, to enter into definitive
agreements to Transfer the Offered Securities not being acquired pursuant to Section 3.3(b) and (c), for consideration having a value not less than 90% of the First Offer Price; provided that any such definitive agreement provides for
the consummation of such Transfer to take place within six months from the date of such definitive agreement and is otherwise on terms not more favorable to the transferee in any material respect than were contained in the Offer Notice. 

(e) If neither the Company nor the ROFO Recipients (in the aggregate) exercise their respective options to purchase all of the Offered
Securities at the First Offer Price and the applicable Offering Holder has not entered into a definitive agreement described in Section 3.3(d) within six months from the date acceptance notices from the ROFO Recipients were due to be received by the
applicable Offering Holder, or the Offering Holder has entered into such an agreement but has not consummated the sale of such securities within six months from the date of such definitive agreement, then the provisions of this Section 3.3
shall again apply, and such Offering Holder shall not Transfer or offer to Transfer such Equity Securities not so Transferred without again complying with this Section 3.3. 

(f) Upon exercise by the Company and/or the ROFO Recipients, as the case may be, of their respective rights of first offer under this
Section 3.3, the Company and/or the ROFO Recipients, as the case may be, and the applicable Offering Holder shall be legally obligated to consummate the purchase contemplated thereby and shall use their commercially reasonable efforts to secure
any governmental authorization required, to comply as soon as reasonably practicable with 'all applicable laws and to take all such other actions and to execute such additional documents as are reasonably necessary or appropriate in connection
therewith and to consummate the purchase of the Offered Securities as promptly as practicable. 
 SECTION 3.4. Right
of Co-Sale on Transfers by Stockholders. (a) In the event of a proposed Transfer of Equity Securities by a Stockholder or any of its Affiliates (a “Transferring Stockholder”), each Stockholder (other than the Transferring
Stockholder) shall have the right to participate in the Transfer in the manner set forth in this Section 3.4. Prior to any such Transfer, the Transferring Stockholder shall deliver to the Company prompt written notice (the “Transfer
Notice”), which the Company will forward to the Stockholders (other than the Transferring Stockholder, the “Co-Sale Participants”), which notice shall state (i) the name of the proposed Transferee, (ii) the number
of Equity Securities proposed to be Transferred (the 

  
 21 

 “Transferred Securities”), (iii) the proposed purchase price therefor, including a
description of any non-cash consideration sufficiently detailed to permit the determination of the Fair Market Value thereof, and (iv) the other material terms and conditions of the proposed Transfer, including the proposed Transfer date (which
date may not be less than thirty-five (35) days after delivery of the Transfer Notice). Such notice shall be accompanied by a written offer from the proposed Transferee to purchase the Transferred Securities. Each Co-Sale Participant may
Transfer to the proposed Transferee identified in the Transfer Notice their Pro Rata Portion of such Co-Sale Participant's Equity Securities by giving written notice to the Company (who shall forward such notice to the other Co-Sale Participants
within five days) and to the Transferring Stockholder within the 30-day period specified in Section 3.3(d), which notice shall state that such Co-Sale Participant elects to exercise its rights of co-sale under this Section 3.4 and shall
state the maximum number of shares sought to be Transferred. In the event any such Co-Sale Participant elects to exercise its co-sale rights with respect to less than all of its Pro Rata Portion (such remaining securities, the “Section 3.4
Non-Electing Shares”), each such other Co-Sale Participant shall be entitled to sell its Pro Rata Portion of the Section 3.4 Non-Electing Shares. Each Co-Sale Participant shall be deemed to have waived its right of co-sale hereunder if
it either fails to give notice within the prescribed time period or if such Co-Sale Participant purchases Equity Securities in exercising its right of first offer pursuant to Section 3.3. The proposed Transferee of Transferred Securities will
not be obligated to purchase a number of Equity Securities exceeding that set forth in the Transfer Notice and in the event such Transferee elects to purchase less than all of the additional Equity Securities sought to be Transferred by the Co-Sale
Participants, the number of Equity Securities to be Transferred by the Transferring Stockholder and each such Co-Sale Participant shall be reduced on a pro rata basis. 
 (b) Each Co-Sale Participant, in exercising its right of co-sale hereunder, may participate in the Transfer by delivering to the Transferring Stockholder at the closing of the Transfer of the Transferring
Stockholder's Transferred Securities to the Transferee certificates representing the Transferred Securities to be Transferred by such holder, duly endorsed for transfer or accompanied by stock powers duly executed, in either case executed in blank
or in favor of the applicable purchaser against payment of the aggregate purchase price therefor by wire transfer of immediately available funds. 
 (c) The following Transfers of Equity Securities by any Stockholder or its Affiliates shall not be subject to the co-sale rights provided by this Section 3.4: (A) Transfers to Permitted
Transferees of such Stockholder (or Permitted Transferees of such Permitted Transferees), or (B) Transfers following an Qualified IPO. 
 SECTION 3.5. Drag Along Right. (a) Subject to the provisions of Section 2.5, following the sixth anniversary of the Closing Date and so long as the Company has not completed an IPO, if
the CD&R Investors, on the one hand, or the KKR. Investors, on the other hand (as applicable, the “Initiating Stockholder”), desire to Transfer a number of shares of Common Stock to a non-Affiliate of such Investor, in a single
transaction or series of related transactions (other than Transfers pursuant to the Registration Rights Agreement or Transfers to any Permitted Transferees of the Initiating Stockholder) such that the transaction would result in a Change of Control
(taking into account all interests being “dragged”) (a “Drag Transaction”), then if requested by the Initiating Stockholder each other Stockholder (together with its Affiliates) (a “Selling Stockholder”)
shall be required to sell the same proportion of its Common Stock as is being Transferred by the Initiating Stockholder of the Common Stock held by it in such Drag Transaction in accordance with this Section 3.5. 

  
 22 

 (b) The consideration to be received by a Selling Stockholder shall be the same form and
amount of consideration per share to be received by the Initiating Stockholder, and the terms and conditions of such Drag Transaction shall be the same as those upon which the Initiating Stockholder sells its Equity Securities; provided that,
without the consent of the Selling Stockholder, the consideration to be received by such Selling Stockholder shall consist solely of cash. In connection with the Drag Transaction, the Selling Stockholder will agree to make or agree to the same
customary representations, covenants, indemnities and agreements as the Initiating Stockholder so long as they are made severally and not jointly and the liabilities thereunder are borne on a pro rata basis based on the consideration to be received
by each Stockholder; provided, however, that (i) any general indemnity given by the Initiating Stockholder, applicable to liabilities not specific to the Initiating Stockholder, to the purchaser in connection with such sale shall be
apportioned among the Selling Stockholders according to the consideration received by each Selling Stockholder and shall not exceed such Selling Stockholder's proceeds from the sale and (ii) any representation relating specifically to a Selling
Stockholder shall be made only by that Selling Stockholder and provided, further, that any representation made by a Selling Stockholder shall relate only to such Selling Stockholder and its Equity Securities. 

(c) Subject to the provisions of Section 2.5, in connection with any Drag Transaction, each Selling Stockholder shall be required to
vote, if required by this Agreement or otherwise, its shares of Common Stock in favor of such Drag Transaction at any meeting of the Company's stockholders called to vote on or approve such Drag Transaction and/or to consent in writing to such Drag
Transaction, to use its reasonable best efforts to cause any individuals designated by such Selling Stockholder to serve on the Board to vote in favor of such Drag Transaction at any meeting of the Board called to vote on or approve such Drag
Transaction and/or to consent in writing to such Drag Transaction, and to waive all dissenters' or appraisal rights, if any, in connection with such Drag Transaction. 
 (d) The fees and expenses, other than those payable to any Stockholder or any of their respective Affiliates, incurred in connection with a Drag Transaction under this Section 3.5 and for the benefit
of all Stockholders (it being understood that costs incurred by or on behalf of a Stockholder for his, her or its sole benefit will not be considered to be for the benefit of all Stockholders), to the extent not paid or reimbursed by the Company or
the Transferee or acquiring Person, shall be shared by all the Stockholders on a pro rata basis, based on the consideration received by each Stockholder; provided that no Stockholder shall be obligated to make any out-of-pocket expenditure
prior to the consummation of the Drag Transaction consummated pursuant to this Section 3.5 (excluding modest expenditures for postage, copies, etc.). 
 (e) The Initiating Stockholder shall provide written notice (the “Drag Along Notice”) to each other Selling Stockholder of any proposed Drag Transaction as soon as practicable following
its exercise of the rights provided in Section 3.5(a). The Drag Along Sale Notice will include the material terms and conditions of the Drag Transaction, including (i) the name and address of the proposed transferee, (ii) the proposed
amount and form of consideration 

  
 23 

 (and if such consideration consists in part or in whole of property other than cash, the Initiating
Stockholder will provide such information, to the extent reasonably available to the Initiating Stockholder, relating to such non-cash consideration as the Selling Stockholders may reasonably request in order to evaluate such non-cash consideration,
provided, however that the provision of such information (or lack thereof) shall not require a Selling Stockholder to accept such non-cash consideration without its prior consent) and (iii) the proposed Transfer date, if known. The Initiating
Stockholder will deliver or cause to be delivered to each Selling Stockholder copies of all transaction documents relating to the Drag Transaction promptly as the same become available. 

(f) If any holders of Equity Securities of any class are given an option as to the form and amount of consideration to be received, all
holders of Equity Securities of such class will be given the same option. 
 (g) At least five Business Days prior to the
consummation of the Drag Transaction, each Selling Stockholder shall deliver to the Company to hold in escrow pending transfer of the consideration therefor, the duly endorsed certificate or certificates representing the Equity Securities held by
such Selling Stockholder to be sold, and a stock power and limited power-of-attorney authorizing the Company to take all actions necessary to sell or otherwise dispose of such securities. In the event that a Selling Stockholder should fail to
deliver the Equity Securities, the Company shall cause the books and records of the Company to show that such Equity Securities are bound by the provisions of this Section 3.5 and that such securities may only be Transferred to the purchaser in
such Drag Transaction. 
 (h) Any Selling Stockholder whose assets (“Plan Assets”) constitute assets of one or
more employee benefit plans and are subject to Part IV of Title I of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), shall not be obligated to sell to any Person to whom the sale of any Equity Securities would
constitute a non-exempt “prohibited transaction” within the meaning of ERISA or the Code, provided, however, that if so requested by the Section 3.5 Transferring Stockholder(s): (i) such Selling Stockholder shall have
taken commercially reasonable efforts to (x) structure its sale of Equity Securities so as not to constitute a non-exempt “prohibited transaction” or (y) obtain a ruling from the Department of Labor to the effect that such sale
(as originally proposed or as restructured pursuant to clause (i)(x)) does not constitute a non-exempt “prohibited transaction” and (ii) such Selling Stockholder shall have delivered an opinion of counsel (which opinion and counsel
are reasonably satisfactory to the Section 3.5 Transferring Stockholder(s)) to the effect that such sale (as originally proposed or as restructured pursuant to clause (i)(x)) would constitute a non-exempt “prohibited transaction.”

 (i) Upon the consummation of the Drag Transaction, the acquiring Person shall remit directly to the Selling Stockholder, by
wire transfer if available and if requested by the Selling Stockholder, the consideration for the securities sold pursuant thereto. 
 SECTION 3.6. Initiation of Qualified IPO. (a) Following the sixth anniversary of the Closing Date, if the Company has not completed a Qualified IPO, each of the Principal Investors shall be
permitted to cause the Company to consummate a Qualified IPO without the consent of the Required Directors, and if a Principal Investor notifies the other Principal Investor 

  
 24 

 and the Company that it intends to exercise its rights hereunder to cause such Qualified IPO, such other
Principal Investor and its Affiliates and the Company shall use their reasonable best efforts to cooperate to cause such Qualified IPO, including, without limitation, causing (in the case of a Principal Investor) its designees on the Board to take
any action required to effect such Qualified IPO and taking all actions required under the Registration Rights Agreement. 
 (b)
At such time as either of the Principal Investors, as applicable, together with their respective Affiliates, shall cease to own a number of shares of Common Stock equal to at least 25% of the outstanding shares of Common Stock, such Principal
Investor, as applicable, shall cease to have any rights to initiate a Qualified IPO under this Section 3.6. 
 SECTION 3.7.
Void Transfers. Any Transfer or attempted Transfer of Equity Securities in violation of any provision of this Agreement shall be void. 
 ARTICLE IV 
 EQUITY PURCHASE RIGHTS 

SECTION 4.1. Equity Purchase Rights. (a) The Company hereby grants to each Stockholder the right to purchase its Pro Rata
Portion of all or any part of New Securities that the Company or any Subsidiary may, from time to time, propose to sell or issue. The number or amount of New Securities which the Stockholders may purchase pursuant to this Section 4.1(a) shall
be referred to as the “Equity Purchase Shares.” The equity purchase right provided in this Section 4.1(a) shall apply at the time of issuance of any right, warrant or option or convertible'or exchangeable security and not to the
conversion, exchange or exercise thereof. 
 (b) The Company shall give written notice of a proposed issuance or sale described
in Section 4.1(a) to the Stockholders within five Business Days following any meeting of the Board at which any such issuance or sale is approved and at least 15 days prior to the proposed issuance or sale. Such notice (the “Issuance
Notice”) shall set forth the material terms and conditions of such proposed transaction, including the name of any proposed purchaser(s), the proposed manner of disposition, the number or amount and description of the shares proposed to be
issued, the proposed issuance date and the proposed purchase price per share, including a description of any non-cash consideration sufficiently detailed to permit the determination of the Fair Market Value thereof. Such notice shall also be
accompanied by any written offer from the prospective purchaser to purchase such New Securities. 
 (c) At any time during the
15-day period following the receipt of an Issuance Notice, the Stockholders shall have the right to elect irrevocably to purchase up to the number of the Equity Purchase Shares at the purchase price set forth in the Issuance Notice (provided
that, in the event any portion of the purchase price per share to be paid by the proposed purchaser is to be paid in non-cash consideration, the value of any such non-cash consideration per share shall be the Fair Market Value thereof) and upon the
other terms and conditions specified in the Issuance Notice by delivering a written notice to the Company. Except as provided in the following sentence, such purchase shall be consummated concurrently with the consummation of the issuance or sale
described in the Issuance Notice. The closing of any purchase by any 

  
 25 

 Stockholder may be extended beyond the closing of the transaction described in the Issuance Notice to the
extent necessary to obtain required governmental approvals and other required approvals and the Company and the Stockholders shall use their respective best efforts to obtain such approvals. 

(d) Each Stockholder exercising its right to purchase its respective portion of the Equity Purchase Shares in full (an
“Exercising Stockholder”) shall have a right of over-allotment such that if any other Stockholder fails to exercise its right hereunder to purchase its full Pro Rata Portion of New Securities (a “Non-Purchasing
Stockholder”), such Exercising Stockholder may purchase its Pro Rata Portion of such securities by giving written notice to the Company within 10 days from the date that the Company provides written notice of the amount of New Securities as
to which such Non-Purchasing Stockholders have failed to exercise their Equity Purchase Rights hereunder. 
 (e) If any
Stockholder or Exercising Stockholder fails to exercise fully the Equity Purchase Right within the periods described above and after expiration of the 10-day period for exercise of the over-allotment provisions pursuant to Section 4.1(d) above,
the Company shall be free to complete the proposed issuance or sale of the New Securities described in the Issuance Notice with respect to which Exercising Stockholders failed to exercise the option set forth in this Section 4.1 on terms no
less favorable to the Company than those set forth in the Issuance Notice (except that the amount of securities to be issued or sold by the Company may be reduced); provided that (x) such issuance or sale is closed within 90 days after
the expiration of the 10-day period described in Section 4.1(d) and (y) the price at which the New Securities are Transferred must be equal to or higher than the purchase price described in the Issuance Notice. Such periods within which
such issuance or sale must be closed shall be extended to the extent necessary to obtain required governmental approvals and other required approvals and the Company shall use its commercially reasonable efforts to obtain such approvals. In the
event that the Company has not sold such New Securities within said 90-day period, the Company shall not thereafter issue or sell any New Securities, without first again offering such securities to the Stockholders in the manner provided in this
Section 4.1. 
 ARTICLE V 
 MISCELLANEOUS 
 SECTION 5.1. Stockholder Indemnification; Reimbursement
of Expenses. 
 (a) Each of the Company and USF, Inc. agrees, on a joint and several basis, to indemnify and hold harmless
each Stockholder, their respective directors, members, managers and officers and their Affiliates (the Stockholders, and the respective directors, officers, partners, members, managers, Affiliates and controlling persons thereof; each, an
“Stockholder Indemnitee”) from and against any and all liability, including, without limitation, all obligations, costs, fines, claims, actions, injuries, demands, suits, judgments, proceedings, investigations, arbitrations
(including stockholder claims, actions, injuries, demands, suits, judgments, proceedings, investigations or arbitrations) and reasonable expenses, including reasonable accountant's and reasonable attorney's fees and expenses (together the
“Losses”), incurred by 

  
 26 

 
such Stockholder Indemnitee before or after the date of this Agreement and arising out of, resulting from, or relating to (i) such Stockholder Indemnitee's purchase and/or ownership of any
Equity Securities, (ii) the transactions contemplated by the Subscription Agreement to which it is a party (including the agreements described therein), and any other subscription agreements pursuant to which any Stockholder Indemnitee
purchased securities of the Company and all agreements contemplated thereby, or (iii) any litigation to which any Stockholder Indemnitee is made a party in its capacity as a stockholder or owner of securities (or a partner, director, officer,
member, manager, Affiliate or controlling person of any Stockholder Indemnitee) of the Company; provided that the foregoing indemnification rights in this Section 5.1 shall not be available to the extent that (a) any such Losses are
incurred as a result of such Stockholder Indemnitee's willful misconduct or gross negligence; (b) any such Losses are incurred as a result of non-compliance by such Stockholder Indemnitee with any laws or regulations applicable to any of them;
(c) any such Losses are incurred as a result of non-compliance by such Stockholder Indemnitee with its obligations under any of the agreements or instruments referenced above or any other agreements or instruments to which such Stockholder
Indemnitee is or becomes a party or otherwise becomes bound; or (d) subject to the rights of contribution provided for below, to the extent indemnification for any Losses would violate any applicable law, regulation or public policy. For
purposes of this Section 5.1, none of the circumstances described in the limitations contained in the proviso in the immediately preceding sentence shall be deemed to apply absent a final non-appealable judgment of a court of competent
jurisdiction to such effect, in which case to the extent any such limitation is so determined to apply to any Stockholder Indemnitee as to any previously advanced indemnity payments made by the Company under this Section 5.1, then such payments
shall be promptly repaid by such Stockholder Indemnitee to the Company. The rights of any Stockholder Indemnitee to indemnification hereunder will be in addition to any other rights any such party may have under any other agreement or instrument
referenced above or any other agreement or instrument to which such Stockholder Indemnitee is or becomes a party or is or otherwise becomes a beneficiary or under law or regulation. In the event of any payment of indemnification pursuant to this
Section 5.1, so long as any Stockholder Indemnitee is fully indemnified for all Losses, the Company will be subrogated to the extent of such payment to all of the related rights of recovery of the Stockholder Indemnitee to which such payment is
made against all other Persons. Such Stockholder Indemnitee shall execute all papers reasonably required to evidence such rights. The Company will be entitled at its election to participate in the defense of any third party claim upon which
indemnification is due pursuant to this Section 5.1 or to assume the defense thereof, with counsel reasonably satisfactory to such Stockholder Indemnitee unless, in the reasonable judgment of the Stockholder Indemnitee, a conflict of interest
between the Company and such Stockholder Indemnitee may exist, in which case such Stockholder Indemnitee shall have the right to assume its own defense and the Company shall be liable for all reasonable expenses therefor. Except as set forth above,
should the Company assume such defense all further defense costs of the Stockholder Indemnitee in respect of such third party claim shall be for the sole account of such party and not subject to indemnification hereunder. The Company will not
without the prior written consent of the Stockholder Indemnitee effect any settlement of any threatened or pending third party claim in which such Stockholder Indemnitee is or could have been a party and be entitled to indemnification hereunder
unless such settlement solely involves the payment of money and includes an unconditional release of such Stockholder Indemnitee from all liability and claims that are the subject matter of such claim. If the indemnification provided for above is

  
 27 

 unavailable in respect of any Losses, then the Company, in lieu of indemnifying an Stockholder Indemnitee,
shall contribute to the amount paid or payable by such Stockholder Indemnitee in such proportion as is appropriate to reflect the relative fault of the Company and such Stockholder Indemnitee in connection with the actions which resulted in such
Losses, as well as any other equitable considerations. 
 The Company agrees to pay or reimburse (i) the Stockholders for
(A) all reasonable costs and expenses (including reasonable attorneys fees, charges, disbursement and expenses) incurred in connection with any amendment, supplement, modification or waiver of or to any of the terms or provisions of this
Agreement, the Subscription Agreement to which it is a party or any related agreements and (B) in connection with any stamp, transfer, documentary or other similar taxes, assessments or charges levied by any governmental or revenue authority in
respect of this Agreement, the Subscription Agreement to which it is a party or any related agreements; and (ii) each Stockholder for all costs and expenses of such Stockholder (including reasonable attorneys fees, charges, disbursement and
expenses) incurred in connection with (1) the consent to any departure by the Company or any of its Subsidiaries from the terms of any provision of this Agreement, the Subscription Agreement to which it is a party or any related agreements and
(2) the enforcement or exercise by such Stockholder of any right granted to it or provided for hereunder. 
 SECTION 5.2.
Termination. Subject to the early termination of any provision as a result of an amendment to this Agreement agreed to by the Board and the Stockholders as provided under Section 5.3 (i) the provisions of Article II shall, with
respect to each Stockholder, terminate as provided in the applicable Section of Article II or, if not so provided, as provided in Section 2.8 (ii) the provisions of Sections 3.3, 3.4, 3.5 and 3.6 and Article IV shall terminate upon the
consummation of a Qualified WO, (iii) the provisions of Section 3.2 shall terminate as provided therein and (iv) Sections 3.1, 3.7 and 5.1 of this Agreement shall not terminate. Nothing herein shall relieve any party from any
liability for the breach of any of the agreements set forth in this Agreement. 
 SECTION 5.3. Amendments and Waivers.
(a) Except as otherwise provided herein, no modification, amendment or waiver of any provision of this Agreement shall be effective without the approval of the Board and each of the CD&R Investors and the KKR Investors; provided,
that any Stockholder may waive (in writing) the benefit of any provision of this Agreement with respect to itself for any purpose. The failure of any party to enforce any of the provisions of this Agreement shall in no way be construed as a waiver
of such provisions and shall not affect the right of such party thereafter to enforce each and every provision of this Agreement in accordance with its terms. Any written amendment or waiver to this Agreement that receives the vote or consent of the
Stockholders provided herein need not be signed by all Stockholders, but shall be effective in accordance with its terms and shall be binding upon all Stockholders. 
 SECTION 5.4. Successors, Assigns and Transferees. This Agreement shall bind and inure to the benefit of and be enforceable by the parties hereto and their respective successors and permitted
assigns. Stockholders may assign their respective rights and obligations hereunder to any Transferees only to the extent expressly provided herein. 

  
 28 

 SECTION 5.5. Legend. (a) All certificates representing the Equity Securities
held by each Stockholder shall bear a legend substantially in the following form: 
 “THE SECURITIES REPRESENTED BY THIS
CERTIFICATE ARE SUBJECT TO A STOCKHOLDERS AGREEMENT (A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY). NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY BE
MADE EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF SUCH STOCKHOLDERS AGREEMENT AND (A) PURSUANT TO A REGISTRATION STATEMENT EFFECTIVE UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) PURSUANT TO AN EXEMPTION FROM REGISTRATION THE REUNDER.THE
HOLDER OF THIS CERTIFICATE, BY ACCEPTANCE OF THIS CERTIFICATE, AGREES TO BE BOUND BY ALL OF THE PROVISIONS OF SUCH STOCKHOLDERS AGREEMENT.” 
 (b) Upon the sale of any Equity Securities pursuant to (i) an effective registration statement under the Securities Act or pursuant to Rule 144 under the Securities Act in compliance with this
Agreement or (ii) another exemption from registration under the Securities Act or upon the termination of this Agreement, the certificates representing such Equity Securities shall be replaced, at the expense of the Company, with certificates
or instruments not bearing the legends required by this Section 5.5; -provided that the Company may condition such replacement of certificates under clause (ii) upon the receipt of an opinion of securities counsel reasonably
satisfactory to the Company. 
 SECTION 5.6. Notices. All notices and other communications required or permitted hereunder
shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified; (b) when sent by confirmed facsimile if sent during normal business hours of the recipient, if not, then on the next
Business Day, provided that a copy of such notice is also sent via nationally recognized overnight courier, specifying next day delivery, with written verification of receipt; (c) five days after having been sent by registered or certified
mail, return receipt requested, postage prepaid; or (d) one Business Day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to such
party’s address as set forth below or at such other address as the party shall have furnished to each other party in writing in accordance with this provision: 
 if to the Company or USF, Inc., to: 
 USF Holding Corp. 

do U.S. Foodservice, Inc. 
 9755 Patuxent Woods Drive 
 Columbia, Maryland 21046 

Attention: David Eberhardt 
 Facsimile: (410) 309-6465 
 with a copy (which shall not constitute notice)
to: 
 Kohlberg Kravis Roberts & Co. L.P. 

  
 29 

 2800 Sand Hill Road, Suite 94025 

Menlo Park, California 94025 
 Attention: Michael Calbert 
 Fax: (650) 233-6548 

and 
 Clayton,
Dubilier & Rice, Inc. 
 375 Park Avenue 

18th Floor 
 New York, New York 10152 
 Attention: Richard J. Schnall 

Fax: (212) 407-5252 
 with a copy (which shall not constitute notice) to: 
 Simpson Thacher &
Bartlett LLP 
 425 Lexington Avenue 
 New York, New York 10017 
 Attention: Marni Lerner, Esq. 

Fax: (212) 455-2502 
 and 
 Debevoise & Plimpton LLP 

919 Third Avenue 

New York, New York 10022 
 Attention: Franci J. Blassberg, Esq. 
 Fax: (212) 909-7531 

if to a KKR Investor, to: 
 Kohlberg Kravis Roberts & Co. L.P. 
 2800 Sand Hill Road, Suite 94025

 Menlo Park, California 94025 
 Attention: Michael Calbert 
 Fax: (650) 233-6548 

with a copy (which shall not constitute notice) to: 
 Simpson Thacher & Bartlett LLP 
 425 Lexington Avenue 

New York, New York 10017 
 Attention: Marni Lerner, Esq. 
 Fax: (212) 455-2502 

  
 30 

 if to a CD&R Investor, to: 

Clayton, Dubilier & Rice, Inc. 
 375 Park Avenue 
 18th Floor 

New York, New York 10152 
 Attention: Richard J. Schnall 
 Fax: (212) 407-5252 

with a copy (which shall not constitute notice) to: 
 Debevoise & Plimpton LLP 
 919 Third Avenue 

New York, New York 10022 
 Attention: Franci J. Blassberg, Esq. 
 Fax: (212) 909-7531 

SECTION 5.7. Further Assurances. At any time or from time to time after the date hereof, the parties agree to cooperate with each
other, and at the request of any other party, to execute and deliver any further instruments or documents and to take all such further action as the other party may reasonably request in order to evidence or effectuate the consummation of the
transactions contemplated hereby and to otherwise carry out the intent of the parties hereunder. 
 SECTION 5.8. Entire
Agreement. Except as otherwise expressly set forth herein, this Agreement together with the Registration Rights Agreement and the Subscription Agreements embody the complete agreement and understanding among the parties hereto with respect to
the subject matter hereof and supersedes and preempts any prior understandings, agreements or representations by or among the parties, written or oral, that may have related to the subject matter hereof in any way. 

SECTION 5.9. Restrictions on Other Agreements; Bylaws. (a) Following the date hereof, no Stockholder or any of its, her or
his Permitted Transferees shall enter into or agree to be bound by any stockholder agreements or arrangements of any kind with any Person with respect to any Equity Securities except pursuant to the agreements specifically contemplated by the
Subscription Agreement to which it is a party and the Registration Rights Agreement. 
 (b) The provisions of this Agreement
shall be controlling if any such provisions or the operation thereof conflict with the provisions of the Company’s by-laws. Each of the parties covenants and agrees to vote their Equity Securities and to take any other action reasonably
requested by the Company or any Stockholder to amend the Company's by-laws so as to avoid any conflict with the provisions hereof. 
 SECTION 5.10. Delays or Omissions. It is agreed that no delay or omission to exercise any right, power or remedy accruing to any party, upon any breach, default or noncompliance by another party
under this Agreement, shall impair any such right, power or 

  
 31 

 remedy, nor shall it be construed to be a waiver of any such breach, default or noncompliance, or any
acquiescence therein, or of or in any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver, permit, consent or approval of any kind or character on the part of any party hereto of any breach, default or
noncompliance under this Agreement or any waiver on such party’s part of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either
under this Agreement, by law, or otherwise afforded to any party, shall be cumulative and not alternative. 
 SECTION 5.11.
Governing Law; Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed in all respects by the laws of the State of New York regardless of the law that might be applied under principles of conflict of laws to the extent such
principles would require or permit the application of the laws of another jurisdiction. No suit, action or proceeding with respect to this Agreement may be brought in any court or before any similar authority other than in a court of competent
jurisdiction in the State of New York, and the parties hereto hereby submit to the exclusive jurisdiction of such courts for the purpose of such suit, proceeding or judgment. Each party hereto hereby irrevocably waives any right it may have had to
bring such an action in any other court, domestic or foreign, or before any similar domestic or foreign authority. Each of the parties hereto hereby irrevocably and unconditionally waives trial by jury in any legal action or proceeding in relation
to this Agreement and for any counterclaim therein. 
 SECTION 5.12. Severability. Whenever possible, each provision of
this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any
jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or
unenforceable provision had never been contained herein. 
 SECTION 5.13. Enforcement. Each party hereto acknowledges
that money damages would not be an adequate remedy in the event that any of the covenants or agreements in this Agreement are not performed in accordance with its terms, and it is therefore agreed that in addition to and without limiting any other
remedy or right it may have, the non-breaching party will have the right to an injunction, temporary restraining order or other equitable relief in any court of competent jurisdiction enjoining any such breach and enforcing specifically the terms
and provisions hereof. 
 SECTION 5.14. Titles and Subtitles. The titles of the sections and subsections of this
Agreement are for convenience of reference only and are not to be considered in construing this Agreement. 
 SECTION 5.15.
No Recourse. Notwithstanding anything that may be expressed or implied in this Agreement, the Company and each Stockholder covenant, agree and acknowledge that no recourse under this Agreement or any documents or instruments delivered in
connection with this Agreement shall be had against any current or future director, officer, employee, general or limited partner or member of any Stockholder or of any Affiliate or 

  
 32 

 assignee thereof, whether by the enforcement of any assessment or by any legal or equitable proceeding, or
by virtue of any statute, regulation or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any current or future officer, agent or
employee of any Stockholder or any current or future member of any Stockholder or any current or future director, officer, employee, partner or member of any Stockholder or of any Affiliate or assignee thereof, as such for any obligation of any
Stockholder under this Agreement or any documents or instruments delivered in connection with this Agreement for any claim based on in respect of or by reason of such obligations or their creation. 

SECTION 5.16. Counterparts; Facsimile Signatures. This Agreement may be executed in any number of counterparts, each of which
shall be an original, but all of which together shall constitute one instrument. This Agreement may be executed by facsimile signature(s). 
 [Rest of page intentionally left blank] 

  
 33 

 IN WITNESS WHERE OF, the parties hereto have executed this Stockholders Agreement as of
the date set forth in the first paragraph hereof. 
  

			
	USF HOLDING CORP.
		
	By:	 	 /s/ Nathan K. Sleeper

		 	Name: Nathan K. Sleeper
		 	Title: Director

  

			
	U.S. FOODSERVICE, INC.
		
	By:	 	 /s/ David B. Eberhardt

		 	Name: David B. Eberhardt
		 	Title: Director

  

			
	KKR 2006 FUND, L.P.
		
	By:	 	KKR Associates 2006 L.P., its General Partner
		
	By:	 	KKR 2006 GP LLC, its General Partner
		
	By:	 	/s/ William J. Janetschek
		 	Name: William J. Janetschek
		 	Title: Director

  

			
	KKR PEI INVESTMENTS, L.P.
		
	By:	 	KKR PEI Associates L.P., its General Partner
		
	By:	 	KKR PEI GP Limited, the General Partner of KKR PEI Associates, L.P.
		
	By:	 	/s/ William J. Janetschek
		 	Name: William J. Janetschek
		 	Title: Director

 [Signature Page to Stockholders Agreement] 

 
			
	KKR PARTNERS III, L.P.
		
	By:	 	KKR DI GP LLC, its General Partner
		
	By:	 	/s/ William J. Janetschek
		 	Name: William J. Janetschek
		 	Title: Director

  

			
	OPERF CO-INVESTMENT LLC
		
	By:	 	KKR Associates 2006 L.P., its Manager
		
	By:	 	KKR 2006 GP LLC, its General Partner
		
	By:	 	/s/ William J. Janetschek
		 	Name: William J. Janetschek
		 	Title: Director

  

			
	CLAYTO, UBILIER & RICE FUND VD, L.P.
		
	By:	 	CD&R Associates VII, Ltd., its General Partner
		
	By:	 	 /s/ Theresa Gore

		 	Name: Theresa Gore
		 	Title: Director

  

			
	CLAYTON, DUBILIER & RICE FUND VII (CO-INVESTMENT), L.P.
		
	By:	 	CD&R Associates VII (Co-Investment), Ltd., its General Partner
		
	By:	 	 /s/ Theresa Gore

		 	Name: Theresa Gore
		 	Title: Director

 [Signature Page to Stockholders Agreement] 

 
			
	CD&R Parallel FUND VII, L.P.
		
	By:	 	CD&R Parallel Fund Associates VII, Ltd., its Partner
		
	By:	 	 /s/ Theresa Gore

		 	Name: Theresa Gore
		 	Title: Director

  

			
	CDR USF CO-INVESTOR L.P.
		
	By:	 	CDR USF Co-Investor GP Limited, its General-partner
		
	By:	 	 /s/ Theresa Gore

		 	Name: Theresa Gore
		 	Title: Director

  

			
	CDR USF CO-INVESTOR NO.2, L.P.
		
	By:	 	 CDR USF Co-Investor GP No.2, its
 General-Partner

		
	By:	 	 /s/ Theresa Gore

		 	Name: Theresa Gore
		 	Title: Director

 [Signature Page to Stockholders Agreement] 

 Exhibit A 
 Assignment and Assumption Agreement 
 Pursuant to the Stockholders
Agreement, dated as of July 3, 2007 (the “Stockholders Agreement”), among USF Holding Corp., a Delaware corporation (the “Company”), U.S. Foodservice, Inc., and each of the stockholders of the Company whose
name appears on the signature pages listed therein (each, a “Stockholder” and collectively, the “Stockholders”),
                    (the “Transferor”) hereby assigns to the undersigned the rights that may be assigned thereunder, and the
undersigned hereby agrees that, having acquired Equity Securities as permitted by the terms of the Stockholders Agreement, the undersigned shall assume the obligations of the Transferor under the Stockholders Agreement. Capitalized terms used but
not defined herein shall have the meanings assigned to them in the Stockholders Agreement. 
 Listed below is information
regarding the Equity Securities: 
 Number of Shares of 
 Common Stock 
  

 
 [Rest of page
intentionally left blank] 

 IN WITNESS WHEREOF, the undersigned has executed this Assumption Agreement as
of                     
  

	
	[NAME OF TRANSFEREE]
	
	  
	Name:
	Title:

  

			
	Acknowledged by:
	
	USF HOLDING CORP.
		
	By:	 	 
		 	Name:
		 	Title:

  

			
	U.S. FOOD SERVICE, INC.
		
	By:	 	 
		 	Name:
		 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}]]